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ABSTRACT

Circuits Underlying Serotonin Mediated Sex Differences in Fear Learning
by
Rebecca Elizabeth Ravenelle
Advisor: Dr. Nesha Burghardt
Post-traumatic stress disorder (PTSD) is a trauma-related disorder characterized by
intense fearful memory formation. Women are twice as likely as men to develop PTSD,
indicating there may be sex differences in the underlying neural circuits. Given that serotonin (5HT) dysfunction is implicated in PTSD, and 5-HT modulates fear learning, we investigated
whether there are sex differences in the modulation of fear learning by 5-HT. We administered
the selective serotonin reuptake inhibitor (SSRI) citalopram (20mg/kg or 10m/kg, i.p.) once to
male and female mice prior to auditory fear conditioning and tested the effects on fear memory
the next day. We found that elevating extracellular levels of 5-HT with citalopram before
learning enhanced fear memory in females at both the low and high dose. In contrast, males only
exhibited a modest elevation in fear memory during recall at the high dose, suggesting females
may be more sensitive to increases in 5-HT than males. The low dose of citalopram also
upregulated learning-induced c-Fos activity in the anterior dorsal bed nucleus of the stria
terminalis (adBNST) and central amygdala (CeA) in females, but not males. To further explore
the role of the extended amygdala in 5-HT mediated increases in fear learning, we
optogenetically stimulated 5-HT terminals in the adBNST during auditory fear conditioning
while simultaneously recording local field potentials in the adBNST in CeA. Similar to what we
found with pharmacological upregulation of serotonin, this manipulation enhanced fear recall in
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females but not males, effects that were associated with greater high gamma (90 – 120 Hz)
coherence between the adBNST and CeA. In females stimulation of 5-HT in the adBNST during
conditioning also upregulated c-Fos in the oval BNST (ovBNST) and CeA, further implicating
outputs to the CeA in the underlying circuitry. To determine if adBNST-to-CeA communication
is necessary for 5-HT mediated increased in fear learning in females, we chemogenetically
inhibited adBNST to CeA projections during conditioning and optogenetic stimulation of 5-HT
in the adBNST. We found that inhibition of this projection significantly reduced recall of a cued
and contextual fear memory, indicating adBNST-to-CeA communication modulates both
auditory and contextual fear learning in females. We may be the first to show that sex differences
in the 5-HT system contributes to greater fear learning in females by differentially affecting
activity within the BNST-CeA circuit. Our findings may provide insight into why women are at a
greater risk of developing PTSD than men and could inform novel treatment options for trauma
exposed women.
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CHAPTER ONE
Introduction
Post-traumatic Stress Disorder
Formally referred to as ‘shell-shock’ or ‘combat exhaustion’, post-traumatic stress
disorder (PTSD) was officially recognized by the American Psychiatric Association in 1980
(DSM-III). Although PTSD is often associated with military combat, it is widely accepted that
PTSD can develop in any individual who has experienced, or witnessed, a traumatic event;
intense fear memory formation associated with the event(s) remains a hallmark of the disorder.
Symptoms vary across individuals but at least four major criteria must be met for a formal
diagnosis: (1) intrusion symptoms, such recurrent negative memories or dissociative reactions
including derealization or depersonalization, (2) avoidant behaviors, (3) negative mood or
cognitive views, and (4) a heightened state of arousal (DSM-5).
Research by the World Health Organization highlights PTSD-risk factors including
trauma type, geography, and gender (Karam et al., 2014; Yehuda et al., 2015). In the United
States, the prevalence of PTSD averages 2.5% amongst the entire adult population (Karam et al.,
2014). Interestingly, women are twice as likely as men to be diagnosed with the disorder (Justice
& Brandt, 2010; Tolin & Foa, 2006) but the reason for this difference is unclear. Although men
and women report statistically similar exposure to overall trauma (Tolin & Foa, 2006), women
are more likely than men to be diagnosed with PTSD after experiencing an assault (Breslau &
Anthony, 2007). There is also evidence symptoms manifest differently in men and women. Men
report more severe hypervigilance-related symptoms while women report more debilitating
mood and cognitive symptoms (King, et al., 2013) and also present with more comorbidities
such as major depressive disorder (Horesh et al., 2015).
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Imaging studies have been used to identify brain regions implicated in PTSD. Early
magnetic resonance imaging (MRI) studies with patients identified decreased hippocampal
volume in military personnel (Gurvits et al., 1996) and in civilians with extensive childhood
trauma (Bremner et al., 1997). Using monozygotic twins discordant for PTSD, Kasai et al.,
(2008) identified PTSD-associated reductions in gray matter density in both the hippocampus
and anterior cingulate cortex (ACC) supporting the hypothesis that reduced volume in these
regions is a consequence of trauma exposure, and not an underlying risk factor for developing
the disorder. Initial MRI studies did not initially reveal volume differences in the amygdala
(Gurvits et al., 1996; Kasai et al., 2008) but recent work using more refined voxel analyses
suggest subtle shape changes within this region in PTSD patients compared to controls (Akiki et
al., 2017). Although early research identified PTSD-related structural changes in the
hippocampus and ACC, these findings do not inform how communication within, or between,
these regions may contribute to symptomology.
Functional neuroimaging studies are more informative of the neural circuitry underlying
PTSD symptomology. Using a trauma-associated exposure paradigm, Shin et al., (1999) found
elevated cerebral blood flow to the ACC in female PTSD patients. Another early functional
study using single photon emission computerized tomography (SPECT) during exposure to
trauma-associated stimuli identified elevated cerebral blood flow to the ACC, left amygdala, and
left extended amygdala (Liberzon et al., 1999). Rauch et al., (2000) utilized a cognitive
activation paradigm (masked-faces protocol designed to minimize prefrontal influence) instead
of exposure to trauma-related stimuli during functional magnetic resonance (fMRI) imaging in
patients to more clearly define the role of the amygdala in symptomology. They found that
individuals diagnosed with PTSD had an exaggerated blood oxygenation level-dependent
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(BOLD) response in the amygdala to masked-fearful faces targets, and this elevated signal
positively correlated with symptom severity. Follow-up fMRI studies confirmed that the
amygdala BOLD response during a masked-face protocol positively correlates with symptom
severity as early as one-month following a trauma (Armony, Corbo, Clément, & Brunet, 2005).
During an overt-face protocol the exaggerated amygdala response was negatively correlated with
BOLD signal in the medial prefrontal cortex (Shin et al., 2005) suggesting elevated amygdala
activity is coupled with reduced prefrontal activity. A review of fMRI studies highlights
amygdala hyperactivity in conjunction with dysregulation of top-down control as playing a key
role in PTSD (Garfinkel & Liberzon, 2009).
Fear Learning
Fear Conditioning As a Model of Fear Learning
For decades, preclinical research has used animal models of psychiatric illness to
characterize neural mechanisms underlying disease development and symptomology. In PTSD
there is evidence of maladaptive emotional learning during exposure to trauma that contributes
importantly to the development of symptomology. An animal model for investigating the
neurobiological basis of PTSD relies on classical Pavlovian fear conditioning. Although PTSD is
a complex disorder, there is high translatability between human fear responses and fear responses
of other species within classical fear conditioning paradigms. Fear conditioning is widely used to
explore the neural circuitry underlying fear memory formation as it relates to psychiatric illness
(Milad & Quirk, 2012; Parsons & Ressler, 2013).
Classic Pavlovian fear conditioning involves pairing a neutral conditioned stimulus (CS,
i.e. tone or light) with an aversive unconditioned stimulus (US, i.e. foot shock). Following
formation of the CS-US association, presentation of the CS alone results in a conditioned
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response (CR, i.e. freezing, startle, autonomic changes) in anticipation of the US. The CR can be
extinguished following repeated CS presentations. Fear conditioning studies in rodents have
involved identifying and manipulating brain regions and neurotransmitter systems underlying
fear memory formation, memory retrieval, and extinction learning in both cued and contextual
paradigms. As a result, the neural circuitry underlying fear learning is well established in the
literature. Research indicates that fear-associated behaviors and brain regions are evolutionarily
conserved across species (Anderson & Adolphs, 2014; Janak & Tye, 2015), implying that
findings from animal model can be used to inform psychiatry.
Cued Fear Conditioning: Regions of Interest
Auditory fear conditioning studies in rodents have identified the amygdala as a key
region underlying cued fear memory acquisition and expression (Phillips & LeDoux, 1992;
Rogan, Staubli, & LeDoux, 1997; Maren, 2001). This almond-shaped brain region is composed
of several sub-regions – including the lateral amygdala (LA), basal amygdala (BA), (often
referred to jointly as the BLA), and the central nucleus of the amygdala (CeA). The CeA is
further divided into lateral (CeL) and medial (CeM) regions. Early work found that sensory
inputs from the cortex and thalamus converge in the LA and mediates conditioned associations
(Doyère, Schafe, Sigurdsson, & LeDoux, 2003; LeDoux, Cicchetti, Xagoraris, & Romanski,
1990). Optogenetic work confirms findings that plasticity within the LA is necessary for the
formation of CS-US associations (Johansen et al., 2010). Originally, research suggested that
during fear conditioning information was transferred from the LA to the CeA, with projections
from the CeA serving only to generate CRs via brainstem structures (i.e. information sent to
periaqueductal gray to generate freezing behavior) (Miserendino, Sananes, Melia, & Davis,
1990; Maren, 2001). However work by Wilensky et al., (2006) illustrated that reversibly
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inactivating the CeA with muscimol prior to fear training impaired fear acquisition, indicating
that this region is involved in fear memory formation. Recent work expands this finding and
suggests that the CeL contributes to fear acquisition and the CeM contributes to fear expression
(Ciocchi et al., 2010; Penzo, Robert, & Li, 2014; Keifer et al., 2015).
Local glutamatergic signaling underlies synaptic plasticity responsible for generating
learned fear behaviors (Ledoux, 2000). Glutamatergic inputs from sensory regions, such as the
auditory cortex and thalamus, converge with aversive inputs from the thalamus or
periacqueductal gray (PAG) onto LA neurons to facilitate long term potentiation (LTP) via
NMDA and AMPA receptors (Johansen, Cain, Ostroff, & Ledoux, 2011; Ledoux, 2000;
Malenka & Nicoll, 1999). Blocking LTP in the LA with NMDA receptor antagonists disrupts
fear acquisition (Rodrigues, Schafe, & LeDoux, 2001) and expression (Maren, Aharonov, Stote,
& Fanselow, 1996) in cued fear conditioning paradigms. Metabotropic glutamate receptors
(mGluR) also contribute to aspects of fear learning within the amygdala. For example, intra-LA
infusions of the mGluR2/3 antagonist FY341495 prior to extinction learning blocks extinction
recall (Kim et al., 2015). Intra-LA infusions of the mGluR5 antagonist 2-methyl-6(phenylethynyl)-pyridine (MPEP) prior to training blocks the acquisition of short-term and longterm cued fear memories (Rodrigues et al., 2002).
In addition to glutamate, local GABAergic signaling also plays a role in mediating fear
learning within the amygdala (Ehrlich et al., 2009). In the LA, LTP induction is facilitated by
antagonizing GABAA or GABAB receptors in vitro (Bissieére, Humeau, & Luüthi, 2003; Tully,
Li, Tsvetkov, & Bolshakov, 2007). Other in vitro work with amygdala interneurons illustrates
that GABAergic signaling can refine glutamate release within the LA. Using a mouse line
lacking GABAB(1a,2) – a subtype of the GABAB receptor – presynaptic inhibition within the LA

5

was greatly reduced and subsequently generalization during a cued fear discrimination task
increased (Shaban et al., 2006). Reducing GABA signaling in mice heterozygous or homozygous
loss of 65kDa-GAD (an enzyme which synthesizes GABA) also resulted in a shift to fear
generalization as evidenced by similar freezing during CS+ and CS- presentations (BergadoAcosta et al., 2008). GABAergic signaling is also vital within the CeA (Ehrlich et al., 2009).
Projections from both the CeL to the CeM are inhibitory. Excitation of CeL interneurons results
in GABAergic inhibition of neurons within the CeM (Huber, Veinante, & Stoop, 2005) which
can attenuate fear responses (Ciocchi et al., 2010).
Fear Learning and the BNST
Johnston (1923) first described the bed nucleus of the stria terminalis (BNST) in several
species and noted its association with other amygdaloid nuclei before it was ultimately grouped
within the extended amygdala – a region which includes the BNST, CeA, and medial amygdala
(MeA) (de Olmos 1971; Alheid et al., 1998). The BNST is sometimes referred to as a ‘relay
center’ between other brain regions involved in reward, anxiety, or stress reactivity. It
communicates with amygdala nuclei, the hippocampus, medial prefrontal cortex (mPFC),
hypothalamus and brainstem regions, such as the periaqueductal gray (Hao et al., 2019; Lebow
& Chen, 2016). Neurons in the BNST are innervated by several neurotransmitter systems
including, catecholamines, monoamines, GABA, acetylcholine, and peptides, such as oxytocin
and corticotropin releasing factor (Crestani et al., 2013; Gungor, Yamamoto, & Pare, 2015;
Hammack et al., 2009). Although neurons within the BNST are primarily GABAergic,
glutamatergic neurons have been identified in ventral subdivisions. The rodent BNST is sexually
dimorphic – it is ~2x larger in males than females, and many neurons express androgen,
estrogen, and progesterone receptors enabling hormone status to differentially impact cellular
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activity (Hines, Allen, & Gorski, 1992; Toufexis, Myers, Bowser, & Davis, 2007; Trainor,
Greiwe, & Nelson, 2006; Whylings, Rigney, Peters, de Vries, & Petrulis, 2020).
In rodents the BNST is composed of at least thirteen subdivisions across an anterior-toposterior axis located dorsal and ventral to the anterior commissure (Dong & Swanson, 2004a,
2004b, 2006; Lebow & Chen, 2016). The anterior subsections of the BNST have recently
received significant attention in mood disorder and fear learning studies. The anterior portion
includes the dorsomedial, dorsolateral, oval, juxtacapsular, ventromedial, ventrolateral, and
fusiform subdivisions (Lebow & Chen, 2016; Turesson, Rodríguez-Sierra, & Pare, 2013).
Bidirectional communication between the BNST and CeA, two important nodes of the extended
amygdala, is well-documented in a rodents. This bi-directional communication is primarily
GABAergic, (Gungor, Yamamoto, & Paré, 2015a) and is more dense between the anterior
subdivisions of the BNST and CeA (Dong & Swanson, 2004a; Goode & Maren, 2017; Gungor
& Paré, 2016a).
Early work in the extended amygdala identified a role for the CeA, but not the BNST, in
fear learning. Irreversible lesions of the CeA, but not the BNST, blocked fear potentiated startle
(Davis, Walker, & Lee, 1997; Hitchcock & Davis, 1991). Infusing the glutamate antagonist
NBQX to inactivate the CeA blocked fear-potentiated startle, but an infusion into the BNST
failed to do so. Interestingly, NBQX in the BNST did block light-enhanced startle, an
intrinsically anxiogenic paradigm which doesn’t rely on a conditioned association (Davis et al.,
2010; Walker & Davis, 1997). Walker and Davis used these findings to propose a specific role
for the BNST in phasic, or innate, fear/anxiety.
Further work found that lesioning the BNST following contextual fear acquisition
resulted in disrupted freezing to the context twenty-four hours later, but lesioning the BNST after
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auditory fear conditioning did not affect learning (Sullivan et al., 2004). Inactivation of the
BNST in animals with, or without, an intact BLA, resulted in a deficit in contextual fear
conditioning but did not affect cued fear conditioning (Zimmerman & Maren, 2011). These
findings further support a role for the BNST in contextual fear conditioning, but not cued fear
conditioning.
Many early studies exploring the role of the BNST in fear learning relied on lesions of
the entire anterior-to-posterior extent of the BNST or the entire anterior portion of the BNST
(Davis et al., 1997; Sullivan et al., 2004; Walker & Davis, 1997; Zimmerman & Maren, 2011).
As a heterogeneous structure, the anterior portion of the BNST alone has seven subdivisions with
distinct efferent projections and neuronal populations (Gungor, Yamamoto, & Pare, 2018; Rimi
Hazra et al., 2011; M. Lebow & Chen, 2016; Rodríguez-Sierra, Turesson, & Pare, 2013;
Yamauchi et al., 2018). Lesioning numerous subdivisions within the BNST may obscure
potential effects of some cellular activity on cued fear conditioning. Haufler et al. (2013) did
single-cell recordings in either the anterolateral or anteromedial BNST in male rats trained in a
cued discrimination paradigm. They identified a subpopulation of neurons in both regions
responsive to the CS+, but only neurons in the anteromedial BNST showed increased
responding during contextual freezing. In cued fear potentiated startle, an intra-BNST oxytocinreceptor antagonist significantly impaired acquisition of a cued fear response (Moaddab &
Dabrowska, 2017) while intra-BNST oxytocin facilitated cued fear-related behavior (Martinon et
al., 2019). Together these findings suggest that the BNST may have a more nuanced involvement
in cued fear conditioning than initially understood.
Clinical Relevance
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In humans the bed nucleus of the stria terminalis (BNST) is approximately 190mm2,
(Avery, Clauss, & Blackford, 2015) and lateral, medial, central and ventral subdivisions have
been identified in post-mortem tissue (Walter, Mai, Lanta, & Görcs, 1991), although imaging
resolution has not advanced to allow separate analysis of these regions in vivo. The human BNST
also has high structural connectivity to the amygdala, nucleus accumbens, hippocampus and
striatum; interestingly women exhibit significantly elevated connectivity between the BNST and
these regions than men (Avery et al., 2014; Flook et al., 2020). Using fMRI, Oler et al., (2012)
established in human adolescents and rhesus monkeys, extremely high resting-state connectivity
between the BNST and the CeA. Follow-up work in non-human primates using tract tracing
confirmed that BNST-CeA communication is bidirectional but CeA-to-BNST projections are
more numerous (Oler et al., 2017). Like rodents, the human BNST is also sexually dimorphic in
size – it is ~2.5x larger in men compared to women (Allen & Gorski, 1990).
Although most known for regulating anxiety responses (Michael Davis et al., 2010), there
has been increased interest in the BNST as a modulator of emotional learning in clinical
populations. Part of this renewed interest stems from recent advances in neuroimaging
technology. Improvement in signal-to-noise ratio with high resolution 3T and 7T fMRI, has only
recently allowed accurate imaging of the BNST in adults (Theiss et al., 2017). Functional studies
show that patients with PTSD have elevated baseline functional connectivity of the BNST to the
striatum, a region associated with reward and motivation. Patients with dissociative PTSD (a sub
classification dominated by symptoms of derealization and depersonalization) show elevated
BNST connectivity to the insula and claustrum, regions associated with anticipatory anxiety and
consciousness/nociception, compared to age-matched controls (Rabellino et al., 2018). In an
fMRI study using an aversive stimuli paradigm, PTSD diagnosed women exhibited sustained
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BNST activation following aversive sound exposure; they also perceived aversive stimuli more
negatively than controls (Brinkmann et al., 2017). Research using healthy volunteers also found
increased BOLD signaling in the BNST during an anticipatory threat task (Somerville, Whalen,
& Kelley, 2010). These findings suggest that elevated BNST activity may contribute to
hyperarousal and altered sensory perception. As the BNST is connected with limbic structures
implicated in emotion and is sexually dimorphic, further research on how this region impacts
fear and PTSD symptomology is warranted.
Fear Learning & Serotonin
Brain regions important for fear learning – the amygdala, hippocampus, BNST, and
prefrontal cortex – all receive serotonergic projections from neurons in the raphe nuclei
(Charnay, 2010; Commons, 2016; Rainnie, 1999) and exhibit diverse serotonergic receptor
expression (Asan, Steinke, & Lesch, 2013; Cornea-Hébert, Riad, Wu, Singh, & Descarries, 1999;
Hoffman & Mezey, 1989; Rainnie, 1999). Serotonergic inputs to the BLA reduce firing rates of
projection neurons via activation of local interneurons (Rainnie, 1999; Stutzmann & LeDoux,
1999). Although the BA and LA receive a dense serotonergic projection, the projection to the
CeA is relatively sparse (Bocchio et al., 2016). Serotonergic neurons increase their firing rates
and 5-HT release with onset of painful stimuli, such as a footshock, which is often used in fear
conditioning (Hashimoto, Inoue, & Koyama, 1999; Schweimer & Ungless, 2010). Similarly,
serotonin (5-hydroxytryptamine; 5-HT) neurons in the raphe nuclei exhibit an upregulation of the
immediate early gene (IEG) c-Fos, following exposure to footshock (Takase et al., 2004).
Extracellular 5-HT levels increase in the BLA during fear acquisition (Yokoyama et al., 2005)
and recall (Zanoveli, Carvalho, Cunha, & Brandão, 2009), indicating that 5-HT can modulate
neuronal activity in the amygdala during fear learning.
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Elevating extracellular 5-HT levels is often done with administration of selective
serotonin reuptake inhibitors (SSRIs) – drugs which block reuptake by the 5-HT transporter
(SERT). Acute systemic SSRI treatment increases extracellular 5-HT availability in brain regions
associated with fear learning (Bosker et al., 2001; Invernizzi, Velasco, Bramante, Longo, &
Samanin, 1997). Interestingly, treatment with the SSRI citalopram prior to contextual fear
conditioning has been found to increase (Montezinho et al., 2010) or decrease (Inoue et al.,
1996) acquisition of contextual fear responses. In male rats, acute systemic injections of the
SSRIs fluoxetine or citalopram prior to fear conditioning enhances cued fear learning (Burghardt
et al., 2004; Ravinder et al., 2013) and upregulates the IEG Arc in the extended amygdala (CeA
and BNST) but not the BLA (Pelrine, Pasik, Bayat, Goldschmiedt, & Bauer, 2016; Ravinder,
Burghardt, Brodsky, Bauer, & Chattarji, 2013). In humans, a single 20mg dose of citalopram
enhanced startle response (Grillon, Levenson, & Pine, 2007) and increased facial fear
recognition (Browning, Reid, Cowen, Goodwin, & Harmer, 2007), indicating that acute
elevation of 5-HT may increase processing of threat or fear-related stimuli. Interestingly, chronic
administration of citalopram did not alter fear potentiated startle in healthy volunteers (Grillon,
Chavis, Covington, & Pine, 2009) but did not impair auditory fear conditioning in male rats
(Burghardt et al., 2004a). The differential effects of acute and chronic SSRI administration on
cued fear learning suggests indicate that short- and long-term increases in 5-HT have divergent
effects on emotional learning.
In addition to simply increasing extracellular 5-HT by blocking SERT, chronic SSRI
administration could be altering receptor expression in the amygdala. Male rats that received
chronic citalopram and displayed impaired extinction learning also had reduced expression of the
NR2B subunit of NMDA receptors in the BLA (Burghardt, Sigurdsson, Gorman, McEwen, &
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Ledoux, 2013). As this subunit is important for synaptic plasticity (Johansen et al., 2011),
alterations of NMDA function in the BLA may be a mechanism by which SSRIs impact fear
learning.
Non-pharmacological manipulations have also been used to investigate the role of 5HT on fear learning. Tryptophan depletion has been used in clinical studies to reduce overall 5HT signaling: as 5-HT is synthesized by tryptophan, this essential amino acid is necessary for
generating 5-HT. Therefore, excluding tryptophan from ones’ diet should greatly reduce the
availability of 5-HT (Van Donkelaar et al., 2011). In healthy individuals tryptophan depletion led
to reduced autonomic response to aversive cues in a visual fear conditioning paradigm in
conjunction with reduced prediction error signaling in the amygdala (Hindi Attar, Finckh, &
Büchel, 2012). In a rat model of tryptophan depletion, 5-HT synthesis was inhibited by
administration of p-chlorophenylalanine and fear-potentiated startle was enhanced compared to
controls (Hughes & Keele, 2006). It is important to note that there is no conclusive evidence that
removal of tryptophan from the diet induces meaningful alterations in 5-HT in the central
nervous system (Van Donkelaar et al., 2011).
Organisms with genetic modifications of the 5-HT system have also been used to explore
the role of 5-HT in fear learning. SERT-knockout (SERT-KO) mice, which have greater
extracellular 5-HT levels than wild-types (Jennings, Lesch, Sharp, & Cragg, 2010) underwent
cued fear conditioning. SERT-KO mice exhibited normal fear acquisition and extinction but
impaired extinction recall (Wellman et al., 2007). Using local field potential recordings during
fear conditioning, SERT-KO mice exhibited enhanced LA-to-mPFC theta synchronization (4 – 8
Hz) and deficits during extinction recall (Narayanan et al., 2011). In SERT-overexpression
(SERT-OE) mice, which have reduced extracellular 5-HT levels, animals exhibited impaired fear
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discrimination in conjunction with reduced theta power in the BLA (Barkus et al., 2014).
Interestingly, synchronized theta oscillations between the BLA and mPFC increase during fear
memory retrieval to threat (Likhtik, Stujenske, Topiwala, Harris, & Gordan, 2014). The effects
of 5-HT on theta in SERT mice suggest that 5-HT levels may modulate BLA theta signal,
thereby facilitating communication between the BLA and mPFC during fear learning. Changes
in SERT activity can also alter 5-HT receptor activity and expression. Increased 5-HT
availability in SERT-KO mice is associated with reduced expression and binding activity of the
inhibitory 5-HT1A receptor (Fabre et al., 2000; Holmes, Yang, Lesch, Crawley, & Murphy,
2003). Decreased 5-HT availability in SERT-OE mice is associated with enhanced 5-HT binding
to the excitatory 5-HT2A receptor (Jennings, Sheward, Harmar, & Sharp, 2008). These findings
indicate that alterations in SERT expression can impact serotonergic communication by altering
extracellular availability of 5-HT and influencing 5-HT receptors.
5-HT receptors produce a neuronal response (i.e. depolarization, hyperpolarization) to 5HT. The 5-HT2 receptor group has been implicated in fear memory and is expressed within the
amygdala. Activation of these receptors produces depolarization via decreased potassium
conductance on both interneurons and principal neurons of the BLA (Bocchio et al., 2016;
McDonald & Mascagni, 2007). Work has shown that acute administration of citalopram prior to
fear recall results in increased fear expression, effects that can be blocked by a 5-HT2C
antagonist, but not a 5-HT3 antagonist (Burghardt, Bush, McEwen, & LeDoux, 2007).
Administration of a 5-HT2A agonist following cued fear acquisition enhanced extinction learning,
while administration of a 5-HT2A antagonist impaired extinction (Zhang et al., 2013). This
suggests that even without SSRI-induced elevations in extracellular 5-HT, the 5-HT2A receptor
modulates conditioned fear. In vitro work has revealed a possible mechanism by which 5-HT2
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receptors in the BLA modulate fear learning – activation of these receptors can induce NMDAreceptor dependent neural plasticity via the PKC pathway (Chen, Hough, & Li, 2003).
The 5HT1 receptor group functions as both a heteroreceptor and an autoreceptor; 5-HT1A
receptors are found on neurons throughout the amygdala and on 5-HT neurons in the raphe
nuclei (Barnes & Sharp, 1999). This receptor type produces hyperpolarization upon activation
(Saha, Gamboa-Esteues, & Batten, 2010). Despite a sparse 5-HT projection to the CeA, neurons
in this region exhibit high levels of the 5-HT1A receptor (Rainnie, 1999). Although several
studies have highlighted the importance of this receptor in innate anxiety (Garcia-Garcia et al.,
2017; Lacivita, Leopoldo, Berardi, & Perrone, 2008) less attention has been paid to the role of 5HT1A signaling in fear learning. Bilateral infusion of a 5-HT1A agonist into the amygdala or
hippocampus attenuated contextual fear conditioning (Li et al., 2006), indicating a role for these
postsynaptic receptors in fear learning. Targeting raphe 5-HT1A autoreceptors with pre-training
administration of 8-OH-DPAT, a 5-HT1A agonist, resulted in reduced recall of a contextual fear
recall (Borelli, Gárgaro, Dos Santos, & Brandão, 2005).
Clinical Relevance
5-HT signaling regulates a vast array of behaviors and physiological processes, many of
which are relevant to PTSD, such as anxiety, moods, vigilance, aggression, and arousal. Early
attempts at gauging 5-HT levels in patients measured 5-HT in the periphery. In combat-related
PTSD cases, plasma levels of 5-HT were significantly lower than healthy controls and correlated
negatively with severity of anxiety-like symptoms (Spivak et al., 1999). However, the major
peripheral serotonin metabolite, 5-HIAA, did not differ between PTSD patients and healthy
controls at baseline (Strawn et al., 2002). Administration of the 5-HT agonist mchlorophenylpiperazine (mCPP) to patients and healthy controls resulted in trauma-related
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flashbacks, or panic attacks, in PTSD patients only (Southwick et al., 1997), indicating altered
sensitivity to this neurotransmitter. Using PET imaging with the SERT radioligand tracer
[11C]AFM, PTSD diagnosis was associated with reduced [11C]AFM binding in the amygdala at
baseline, indicating 5-HT dysregulation within a brain region greatly implicated in the
development of PTSD (Murrough et al., 2011).
Genetic variation in 5-HT transmission has also been studied. Polymorphisms of the
SERT gene have been linked to PTSD or mood disorders. Analyses of two variations within the
promoter region of the SERT gene – a long (l) or short allele (s) variation – reveal that the s
allele variation is associated with reduced SERT expression. Lee et al., (2005) found males and
females with PTSD were significantly more likely to have the s/s genotype compared to healthy
controls. This suggests that genetic susceptibility for PTSD development may be associated with
reduced reuptake of 5-HT. In a study of over 400 individuals who experienced a traumatic
natural event, those who developed PTSD were more likely to have the s/s allelic variation, but
only if they also experienced low social support. Therefore the s/s variation alone may not be
enough to predispose an individual to PTSD following trauma (Kilpatrick et al., 2007). Genetic
studies of allelic variation remain controversial as they are not consistently replicated (Grabe et
al., 2009).
The therapeutic effects of medication that directly targets 5-HT neurotransmission
provides significant evidence that dysregulation of this neurotransmitter contributes to PTSD.
SSRIs were introduced in the late 1980s to treat major depressive disorder but were also quickly
prescribed to treat a variety of anxiety disorders and PTSD. The primary mechanism of SSRI
action is to block the serotonin transporter – preventing neurotransmitter reuptake and increasing
available 5-HT. In a randomized double-blind study, male and female PTSD patients showed
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significant symptom improvement after twelve weeks of fluoxetine compared to placebo,
although many participants saw improvement at four weeks (Connor, et al., 1999). A large multiclinic study using both men and women found that sertraline significantly improved arousal and
avoidance symptoms compared to placebo. Sertraline also moderately improved intrusion
symptoms, although this finding did not reach significance (Brady et al., 2000). These findings
strongly suggest a role for 5-HT dysfunction in PTSD. In a follow-up study, Seedat et al., (2004)
used SPECT imaging in PTSD patients before and after eight weeks of citalopram treatment.
Symptom improvement was accompanied by a significant increase in left medial prefrontal
cortical activity, indicating a role for this region in mediating the therapeutic effects of SSRIs.
Despite some success in larger clinical trials, SSRI treatment is not always effective. A
twelve-week study in male combat veterans found no improvement in symptom severity with
fluoxetine (Hertzberg et al., 2000). Hertzberg et al., (2000) account for this discrepancy by
referring to differences in patient populations across studies. While their research focused on
severe chronic combat-related cases in males only, previous work showing that SSRIs are
effective in PTSD included civilians and women. Interestingly, the authors make this argument
despite only studying twelve subjects – six received fluoxetine – signifying sample size
limitations may have influenced their findings. Indeed, an analysis of the literature suggests that
women with PTSD may respond more positively than men to SSRIs. However this could be due
to differences between the sexes in symptom severity at treatment onset, or time between trauma
exposure and diagnosis (Bernardy & Friedman, 2015).
In addition to variable treatment outcome, SSRIs also exhibit a therapeutic lag. Serotonin
availability is elevated immediately upon starting pharmacological treatment, but patients do not
experience symptom relief for several weeks (Quitkin et al., 1997; Taylor et al., 2006).
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Additionally, adverse reactions or worsening of symptoms can occur with initial treatment
(Breggin, 2003; Dording et al., 2002; Ferguson, 2001; Spigset, 1999). This time-lag suggests that
although 5-HT dysregulation is likely contributing to symptomology, simply elevating available
5-HT is not the primary mechanism underlying the therapeutic effects of SSRIs. Despite
treatment outcome disparities, SSRIs are listed by the American Psychiatric Association,
Veterans Affairs, and Department of Defense as first line treatments for PTSD along with
exposure or cognitive behavioral therapy (Yehuda et al., 2015). In the United States, only
sertraline and paroxetine have received Food and Drug Administration approval for PTSD
treatment, however other SSRIs, particularly fluoxetine, are often prescribed ‘off-label’ in
conjunction with therapy (Bernardy & Friedman, 2015).
Sex Differences in the Serotonin System
Early work comparing male and female rodents indicated that females have elevated
serotonergic activity throughout the whole brain (Giulian, Pohorecky, & McEwen, 1973; Kato,
1959; Rubinow, Schmidt, & Roca, 1998). Females exhibit increased 5-hydroxyindoleacetic acid
(5-HIAA), the main metabolite of 5-HT, when measured peripherally compared to males
(Carlsson & Carlsson, 1988). Female rodents also exhibit 53% more 5-HT synthesis in the
hippocampus than males and have elevated 5-HT1A mediated activity in this region (Haleem et
al., 1990). These findings were supported in humans by a PET study of healthy men and women
– researchers found that women exhibit elevated 5-HT1A radioligand binding compared to men,
but lower SERT binding in the hippocampus and prefrontal regions (Jovanovic et al., 2008). This
difference in serotonergic activity in the hippocampus could lead to sex differences in contextual
fear conditioning. Interestingly, within prefrontal cortices women exhibit less 5-HT2 receptor
binding than men (Biver et al., 1996). Greater 5-HT binding to the inhibitory 5-HT1A receptor in
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conjunction with reduced 5-HT binding to the excitatory 5-HT2 receptor highlights two pathways
serotonergic activity leads to reduced neuronal activation in women. Examination of the BLA
revealed that extracellular levels of 5-HT are similar in male and female rats at baseline, but
females exhibit a greater increase in 5-HT availability during restraint stress compared to males
(Mitsushima, Yamada, Takase, Funabashi, & Kimura, 2006) suggesting 5-HT release in the BLA
may only be sexually dimorphic during behavioral challenges.
There is also evidence that cycling hormones in females influence the serotonergic
system. 5-HT neurons in the dorsal raphe nucleus (DRN) express the estrogen receptor beta
(ER) (Suzuki et al., 2013). In ovariectomized adult female rats an eight day injection protocol
of an ER agonist elevated tryptophan hydroxylase 2 (TPH2; the rate limiting enzyme for 5-HT
synthesis) mRNA in the DRN (Donner & Handa, 2009) and was associated with greater
anxiolytic activity. Targeting the DRN directly with either an ER agonist or estrogen, also
upregulated TPH2 mRNA (Donner & Handa, 2009) suggesting elevated estrogen levels can alter
5-HT synthesis in the DRN.
Acute estradiol injection in ovariectomized rats reduced 5-HT receptor density within the
forebrain, but elevated 5-HT receptor levels 72 hours later, indicating a biphasic response to
hormone elevation (Biegon & McEwen, 1982). However, it is important to note this study did
not differentiate between receptor subtypes so it is difficult to determine how downstream
neuronal activity was affected. Two weeks of estradiol treatment also decreased 5-HT1 receptor
expression throughout the forebrain of ovariectomized rats in follow-up experiments (Biegon,
Reches, Synder, & McEwen, 1983). In ovariectomized non-human primates, one-month of
estradiol, or estradiol + progesterone treatment, lowered 5-HT1A but not 5-HT2C levels compared
to ovariectomized controls. However, in animals that received five months of estradiol or
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estradiol + progesterone treatment, 5-HT1A receptors were only reduced in the estrogen +
progesterone group. After five months, 5-HT2C receptor levels were increased with estradiol only
treatment but significantly decreased with estradiol + progesterone treatment (Henderson &
Bethea, 2008). Taken together these findings suggest that extended estradiol elevation does not
regulate 5-HT1A levels, but does induce regulation of 5-HT2C, with progesterone potentially
normalizing expression. These findings highlight the complexities of determining how
circulating hormones may contribute to sex differences in serotonergic signaling in the central
nervous system.
The Role of the BNST & Serotonin in Cued Fear Learning
Previous research suggests the BNST may play a significant role in mediating fear
learning during times of elevated 5-HT availability. Acute systemic injection of the SSRI
fluoxetine prior to fear conditioning enhances fear recall and upregulates IEG activity in the
BNST and CeA, but not the BLA. This behavioral effect is recapitulated by direct infusion of
fluoxetine into the BNST but not the CeA. The intra-BNST infusion also enhances IEG activity
within the CeA (Ravinder et al., 2013), suggesting that the BNST may be a primary site of action
of SSRIs following acute injection. When acute systemic citalopram is instead administered
immediately prior to recall, there is also an elevation in freezing response to the CS, an effect
that is blocked by the 5-HT2C antagonist SB242084 (Burghardt et al., 2007). Other studies
replicate the acute effects of citalopram on cued fear learning and report an associated
upregulation of IEGs in the oval BNST (ovBNST) – a subdivision of the anterior BNST.
Interestingly, a majority of these neurons express the 5-HT2C receptor, suggesting that binding to
this receptor may underlie the enhanced fear response. An intra-ovBNST infusion of the 5-HT2C
antagonist RS102221 eliminated citalopram-induced elevations in fear (Pelrine et al., 2016),
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indicating that the ovBNST may be able to drive SSRI-enhanced fear learning in a 5-HT2C
dependent manner.
Similar to what was found with local infusions of an SSRI, optogenetic activation of 5HT terminals in the anterior BNST paired with CS presentation during training resulted in a
significant elevation in both cued and contextual fear response. In vitro recordings found that
application of a 5-HT2C antagonist blocked the neuronal excitation induced by optogenetic
activation of this projection. Using a targeted DREADD technique researchers found that
activating only 5-HT2C containing neurons in this region increased anxiety-like behaviors
(Marcinkiewcz, Mazzone, D’Agostino, Halladay, Hardaway, Diberto, et al., 2016a) but the direct
impact on fear learning with this technique was not thoroughly explored.
Although particular attention has been paid to the 5-HT2C receptor in fear learning, the
anterolateral BNST (alBNST) contains an array of 5-HT receptors that could also be involved.
The 5-HT1A, 5-HT2A/C, and 5-HT7 receptor subtypes are the most commonly expressed in the
alBNST (Hammack et al., 2009). In vitro electrophysiological analysis indicates that 5-HT
release in the alBNST can cause inhibition via the 5-HT1A receptor, however excitation is caused
primarily by 5-HT2A/C and 5-HT7 receptors (Hammack et al., 2009). Additionally, there is
evidence for serotonergic plasticity within the alBNST after exposure to aversive stimuli. In male
rodents repeated foot shocks led to a significant decrease in 5-HT1A mRNA in the alBNST, while
mRNA levels for 5-HT1B, and 5-HT7 significantly increased. Interestingly, there was no
significant change in 5-HT2C expression (Hazra, Guo, Dabrowska, & Rainnie, 2012).
Rationale for Current Research
Overall the literature suggests that the BNST is not typically required for cued fear
conditioning, but it may be recruited into the fear circuit during times of elevated 5-HT
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availability. Nearly all preclinical work exploring the role of 5-HT neurotransmission in the
BNST on cued fear learning was completed in male rats despite documented sexual dimorphism
in this area. One research group used both male and female mice but did not analyze each sex
separately (Marcinkiewcz et al., 2016). Exploring how serotonergic neurotransmission affects
the BNST is a unique opportunity to understand how a fear circuit may contribute to sexually
dimorphic behavior. In this study I plan to test whether there are sex differences in fear learning
during times of elevated 5-HT availability within the BNST. Then I will determine how the
BNST communicates with the CeA, a vital structure for generating fear responses. Lastly, I will
determine if BNST-to-CeA communication is necessary for the generation of fear responses
during times of heightened 5-HT availability.
Specific Aims
1. Is there a sexually dimorphic response to SSRI-induced increases in fear learning?
To address this question, intact female mice will undergo auditory fear conditioning and
estrous cycle monitoring to determine if there is an association between hormone status and
freezing behavior. Male mice and a separate cohort of female mice will then receive an acute
systemic high (20mg/kg) or low (10mg/kg) dose of the SSRI citalopram prior to auditory fear
conditioning to determine if there is a sexually dimorphic effect of elevated 5-HT availability on
fear learning. A subset of males and females will be euthanized following fear conditioning for
IEG analyses in the BNST and amygdala.
2. How do increases in serotonin in the BNST during fear conditioning influence communication
in the extended amygdala?
To address this question, genetically modified male and female mice will undergo
bilateral fiber optic implantation into the anterodorsal BNST (adBNST). These mice carry
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channelrhodopsin exclusively in 5-HT neurons (TpH2-ChR2-EYFP mice) ensuring that
optogenetic activation manipulates 5-HT release with temporal and regional specificity. During
fear training optogenetic manipulation will occur concurrently with tone presentation (laser on)
and twenty-four hours later animals will be tested for cued recall (laser off). A subset of animals
will be euthanized following training for IEG analysis in the BNST and amygdala. In addition to
fiber optic implantation, a group of males and females will undergo implantation of tungsten
wires within the adBNST and CeA to record local field potentials during fear learning.
MATLAB scripts will be generated to analyze electrophysiological data.
3. Is BNST-to-CeA communication necessary for 5-HT enhanced cued fear learning?
Findings from chapters two and three indicate a sexually dimorphic response to elevated
5-HT availability in the BNST. Females exhibit enhanced freezing during cued recall, greater
IEG activity in the BNST and CeA, and greater gamma coherence in BNST-to-CeA signal
compared to males. To determine if BNST-to-CeA communication is necessary for this
enhanced response, retrograde inhibitory DREADDs (designer receptors exclusively activated by
designer drugs) will be injected into the CeA of female TpH2-ChR2-EYFP mice and bilateral
cannula will be placed into the adBNST. Prior to fear training CNO will be infused via cannula
into the adBNST to inhibit only CeA projecting neurons only. During fear training optic fibers
will be inserted through the cannula to stimulate 5-HT terminals concurrently with CS
presentation. This experiment will determine if the BNST-to-CeA projection is necessary for the
enhanced fear response seen during recall in females.
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CHAPTER TWO
Acute Systemic Citalopram Induces a Sexually Dimorphic Fear Response in Mice
Post-traumatic stress disorder (PTSD) is characterized by intense fearful memory
formation and maladaptive emotional learning during trauma exposure (Yehuda et al., 2015). An
animal model often used to investigate neural circuits underlying fear memory formation is
Pavlovian fear conditioning. In this paradigm a neutral conditioned stimulus (CS, i.e. tone) is
paired with an aversive unconditioned stimulus (US, i.e. foot shock). Following repeated pairings
a CS-US association is formed. Later, presentation of the CS alone results in a conditioned
response (CR, i.e. freezing) in anticipation of the US. The circuitry underlying fear learning is
evolutionarily conserved across species (Anderson & Adolphs, 2014; Janak & Tye, 2015) and is
well established in the literature. Acquisition and expression of cued fear relies on the amygdala
(Ciocchi et al., 2010; Maren, 2001; Phillips & LeDoux, 1992).
There is evidence implicating the neurotransmitter serotonin (5-HT) in fear memory
formation. The amygdala expresses a variety of 5-HT receptors and receives a dense 5-HT
projection from the raphe nuclei (Cornea-Hébert et al., 1999; Hoffman & Mezey, 1989; Rainnie,
1999). Extracellular 5-HT levels increase in the basolateral amygdala (BLA) during acquisition
(Yokoyama et al., 2005) and recall (Zanoveli et al., 2009), implicating a role for 5-HT in fear
learning. Selective serotonin reuptake inhibitors (SSRIs) are used to treat depression and mood
disorders and elevate extracellular 5-HT levels by blocking the serotonin transporter (SERT).
Acute SSRI treatment has consistently proven to elevate central nervous system 5-HT levels
(Invernizzi et al., 1997; Montezinho et al., 2010) particularly in regions important in fear
learning. In vivo rodent work confirms that acute systemic administration of the SSRI citalopram
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increases 5-HT in the central nucleus of the amygdala (CeA) by approximately 175% (Bosker et
al., 2001).
Previous research has identified the bed nucleus of the stria terminalis (BNST) as playing
an important role in mediating the effects of SSRIs on fear learning. The BNST is a sexually
dimorphic structure that together with the CeA and medial amygdala (MeA) amygdala comprise
the extended amygdala (Alheid et al., 1998; Avery et al., 2015; Flook et al., 2020). An acute
systemic injection of citalopram or fluoxetine prior to fear conditioning enhanced fear responses
and upregulated immediate early gene (IEG) activity in the BNST and CeA (Burghardt et al.,
2004; Pelrine, Pasik, Bayat, Goldschmiedt, & Bauer, 2016; Ravinder, Burghardt, Brodsky,
Bauer, & Chattarji, 2013). An intra-anterodorsal BNST (adBNST) infusion of SSRI prior to
training also enhances fear memory formation and upregulates IEG activity within the CeA
(Ravinder et al., 2013). Similarly, optogenetic stimulation of 5-HT projections to the adBNST
during training resulted in an enhanced fear response (Marcinkiewcz et al., 2016). These results
confirm that during times of elevated 5-HT availability the BNST is recruited into the fear
circuit, even though it is not typically required for fear learning (Davis et al., 1997; Davis et al.,
2010).
Women are twice as likely as men to develop PTSD (Justice et al., 2010; Tolin & Foa,
2006), indicating that there may be sex differences in the neural circuits underlying fear learning.
Indeed, sex differences in cued fear learning have previously been noted in rodents. Intact
females exhibit elevated freezing to cues (Gresack, Schafe, Orr, & Frick, 2009) and slower
extinction learning compared to males (Baran, Armstrong, Niren, Hanna, & Conrad, 2009).
Hormones may influence conditioning – elevated estradiol and progesterone facilitate extinction
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learning (Milad et al., 2009) and ten days of treatment with estradiol in ovariectomized mice
enhanced CS-induced fear responses (Jasnow, Schulkin, & Pfaff, 2006).
There is also evidence of sexual dimorphism within the serotonin system. 5-HT neurons
densely express estrogen receptor beta (ER) (Suzuki et al., 2013) and ER agonists elevate
tryptophan hydroxylase 2 (TPH2) mRNA, the rate limiting enzyme for 5-HT synthesis in these
neurons (Donner & Handa, 2009). Cycling hormones can therefore modulate 5-HT synthesis.
Hormones can also influence SSRI response. An intra-hippocampal infusion of the SSRI
fluvoxamine increased time of 5-HT availability in males and females, with the exception of
females in proestrus. A follow-up experiment in ovariectomized rats found that treatment with
estradiol + progesterone also blocked the effect of fluvoxamine on 5-HT clearance (Benmansour,
Piotrowski, Altamirano, & Frazer, 2009), suggesting that hormone status can interact with SSRI
efficacy. Although acute fluoxetine treatment 30 min prior to extinction learning does not induce
a sexually dimorphic fear response, 14 days of fluoxetine treatment administered between fear
conditioning and extinction training, does reduce extinction recall in females , particularly in
those in low estrogen phases (metestrus/diestrus) (Lebrón-Milad, Tsareva, Ahmed, & Milad,
2013). These findings suggests that hormone status may influence efficacy of chronic, not acute,
SSRI administration.
Given the sexually dimorphic nature of the BNST, 5-HT neurotransmission, and fear
learning, the focus on males in previous work leaves us with an incomplete understanding of
how these systems may interact. In the present study we used auditory fear conditioning to
examine whether there is an association between hormone status in female mice and fear
acquisition or recall. We next tested the effects of acute systemic administration of citalopram
prior to auditory fear conditioning on memory retrieval in male and female mice. We also
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characterized associated changes in c-Fos activity within the adBNST and CeA in both sexes.
Our findings demonstrate that there is an SSRI-induced sex difference in fear learning thatmay
be mediated by cellular activity within the extended amygdala.
METHODS
Animals
Approximately twelve week old male and female SJL-Tg (Tph2-COP4*H134R/EYFP)
5Gfng/J mice (C57BL/6J background) were group housed (2 – 4 cage) with food and water
available ad libitum. Animals were bred and housed at the Hunter College Animal Care Facility
where they were maintained in a temperature controlled room on a 12- hour light/dark cycle with
lights on 08:00-20:00. All procedures were approved by the Hunter College Institutional Animal
Care and Use Committee.
Estrous Cycle Monitoring
Vaginal cytology was used to monitor estrous cycle and has been described in detail
elsewhere (Mennenga & Bimone-Nelson, 2015). Briefly, animals were temporarily removed
from the home cage and a cotton swab soaked with 0.9% sterile saline was shallowly inserted
into the vaginal canal to collect cells. The animal was returned to the home cage and the swab
was rolled onto a blank slide for imaging. Cell composition was viewed under bright field
microscopy. Swabbing was conducted a minimum of 60min prior to behavioral testing.
Drug Administration
Citalopram hydrobromide was purchased from Millipore Sigma (St. Louis, MO, USA),
dissolved in 0.9% sterile saline and injected intraperitoneally (i.p.) at either a high (20mg/kg) or
low (10mg/kg) dose (Burghardt et al., 2004; Pelrine et al., 2016) .
Fear Conditioning
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Apparatus
Mice underwent fear conditioning in Med Associates chambers (Fairfield, VT, USA)
constructed of plexiglass and aluminum walls with a stainless steel rod floor capable of
delivering a scrambled foot shock. The house light was off during training and the contextual
recall test, but overhead lamps with adjustable luminance settings maintained light levels at ~30
lux. The conditioning box and grid floor were cleaned with ethanol. During cued recall, mice
were placed in a custom constructed gray wood box with high walls and a smooth floor.
Overhead adjustable lamps maintained light levels at ~70lux and orange scented Clorox wipes
were used to clean between animals and provide a distinct odor within the cued-recall chamber.
Auditory tones and foot shocks were delivered via custom Med-PC scripts (Med Associates,
Fairfield, VT, USA). All behavior was recorded using an infrared OptiTrack camera and
Neuromotive software running in conjunction with Central (Blackrock Microsystems, Salt Lake
City, UT, USA). Timestamps of all stimuli were extracted from Central-generated NEV files in
MATLAB. Behavior was hand-scored for freezing which was defined as cessation of all
movement with the exception of respiration (Velasco, Florido, Milad, & Andero, 2019a).
Fear Conditioning Procedure
Animals were handled for 3 days, 5 min each, prior to habituation. Animals were moved
from the animal facility to the holding area a minimum of 60 min prior to the start of behavioral
testing on days 1 – 5. On days 1 – 2 animals were habituated to the training and recall contexts
for 20 min each. On day 3, animals received an i.p. injection of 20mg/kg or 10mg/kg citalopram
or saline 60 min prior to training. Training consisted of 5 conditioned stimulus presentations
(CS: 2kHZ tone, 85dB, 30s) co-terminating with an unconditioned stimulus (US: 0.7mA
footshock, 2sec). The first CS-US pairing occurred 120sec after start of training and inter-trial
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interval was randomly generated by Med-PC script for each animal and ranged from 90 – 120
sec. On day 4, animals were placed in the testing chamber for 10 CS presentations. The first CS
occurred at 120 sec, then inter-trial interval was randomly generated from 90 – 120 sec. On day
5, animals were placed back in the conditioning chamber for 5 min.
Immunohistochemistry
One hundred sixty minutes after drug injection (90 min after conditioning), mice were
deeply anesthetized with a mixture of ketamine (100mg/kg, i.p.) and xylazine (7 mg/kg, i.p.) and
transcardially perfused with ice cold 1% PBS followed by 4% paraformaldehyde-PBS. Brains
were removed and postfixed in 4% paraformaldehyde-PBS for 24 hr then cryoprotected in 30%
sucrose-0.1%NaN3-PBS for 5 days. Brains were then encased in tissue freezing medium (Sakura
Finetek, Torrance, CA, USA), frozen with dry ice, and stored at -20oC before a cryostat was used
to cut 35µm sections. Every 6th section containing the extended amygdala was processed for cFos immunoreactivity. Sections were washed in 1%PBS (3x, 10min), washed in 1%TritonX 100PBS (30 min) and blocked in 5% normal donkey serum-TritonX-PBS for 1hr at room
temperature. Sections were incubated overnight at 4 oC in anti-c-Fos primary antibody (rabbit
polyclonal, 1:2k dilution, Abcam, Cambridge, MA, USA) in 5%NDS-TrixonX-PBS. Sections
were then washed and incubated for 1hr at room temperature in Alexa Fluor donkey anti-rabbit
488 secondary antibody (Alexa Fluor, 1:500 dilution, ThermoFisher Scientific, Waltham, MA,
USA) in 1%PBS. Sections were mounted on electrostatic slides and cover slipped with ProLong
Gold antifade mounting medium (ThermoFisher Scientific, Waltham, MA, USA). BNST and
CeA sections were imaged using a Nikon A1 confocal microscope (Melville, NY, USA) and cell
counting was done manually using ImageJ.
Statistics
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Statistical analysis was performed using GraphPad Prism 9 (San Diego, CA, USA). All
data are expressed as mean + SEM and significance was defined as p < 0.05. Group differences
across tones were determined using a repeated measures two-way ANOVA followed by Tukey’s
test for multiple comparisons. A mixed-model ANOVA was used in one instance due to a
technical error resulting in a missing data point. Group means were compared using an unpaired
two-tailed t-test (in the case of two groups) or one-way ANOVA (in the case of three groups).
Immunohistochemical data were analyzed with a two-way ANOVA and Tukey’s test for
multiple comparisons.
RESULTS
There is no association between female estrous cycle and cued fear acquisition or recall.
Intact freely cycling females underwent daily vaginal cytology to determine if hormone
status is associated with levels of fear learning as measured by tone-evoked freezing behavior
(Figure 1A). Based on cell composition in vaginal smears (Mennenga & Bimone-Nelson, 2015)
females were separated into either a Low Estradiol (metestrus/diestrus) or a High Estradiol
(proestrus/estrus) group (Figure 1B). When females were grouped according to conditioning day
status, there were no significant differences between Low (n = 15) and High (n = 12) Estradiol
groups in freezing behavior across all tones (F(1,25) = 0.06, p = 0.8044; Figure 1C1). There was a
main effect of tone (F(4,100) = 435.03, p < 0.0001) but no significant interaction (F(4,100) = 1.04, p
= 0.3907). There was also no significant difference in average freezing across tones 2 – 5 (t(25) =
03746, p = 0.7111; Figure 1C2). We also detected no relationship between hormone status on
conditioning day and fear recall the next day (F(1,25) = 0.0408, p = 0.8416; Figure 1D1). While
there was a main effect of tone (F(9,225) = 9.5393, p < 0.0001), there was no significant interaction
between tone and hormone status on conditioning day (F(9,225) = 1.151, p = 0.3278). When only
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the first 5 tones were analyzed, we found no significant group difference in recall (t(25) = 0.5573,
p = 0.5823; Figure 1D2). We also detected no relationship between hormone status during
conditioning day and context recall. Analysis of all five minutes revealed no effect of hormone
status (F(1,24) = 0.17, p = 0.6878; Figure 1E1), a main effect of time (F(4,96) = 5.61, p = 0.004) and
no significant interaction (F(4,96) = 0.57, p = 0.6831). When average freezing over the entire
contextual recall test was compared, there was no significant influence of hormone status (t(24) =

Figure 1. Estrous cycle does not influence auditory or contextual fear learning. (A) Timeline of swabbing and fear
conditioning paradigm. (B) Example images of vaginal cytology across low (metestrus/diestrus) and high (proestrus/estrus)
estradiol states of the estrous cycle. Metestrus: keratinized needle-like, nucleated epithelial, and leukocytes. Diestrus:
predominantly leukocyte, cornified. Proestrus: small rounded cells clustered. Estrus: Cornified cells. (C1) Low (n = 15) or High
(n = 12) Estradiol status did not impact fear acquisition across 5 CS-US pairings and (C2) there is no impact on average freezing
to tones 2 – 5. (D1) Twenty-four hours later, hormone status on conditioning day did not influence freezing across 10 CS
presentations or (D2) when tones 1 – 5 were compared. (E1) Twenty-four house later, hormone status on conditioning day did not
influence context recall when examined across the 5 minutes or (E2) when average freezing was analyzed. When animals were
instead grouped by hormone status on the day of testing (F1) there were was no significant influence across 10 CS presentations
(Low n = 14; High n = 13) or when early recall, (F2) tones 1 – 5 were compared. (G1) Twenty-four hours later there was no
significant influence of hormone status across the contextual recall test (Low n = 13; High n = 13) or (G2) when average freezing
was analyzed. Data presented as mean + SEM and p < 0.05.

30

0.4068, p = 0.6878; Figure 1E2). One animal was excluded from the context recall data due to
technical problems with recording.
We next compared females separated into Low (n = 14) or High (n = 13) Estradiol groups
based on vaginal cytology on the day of testing. On the day of recall, we again found no effect of
hormone status (F(1,25) = 0.6918, p = 0.4134; Figure 1F1), a main effect of tone (F(9,225) = 9.608, p
< 0.0001), and no significant interaction (F(9,225) = 1.406, p = 0.1866). There was no difference
between groups when only the first five recall tones were analyzed (t(25) = 1.783, p 0.0868;
Figure 1F2). During five minutes of contextual recall, we found no significant effect of hormone
status (F(1,24) = 2.286, p = 0.1436; Figure 1G1), a significant effect of time (F(4,96) = 5.887, p =
0.0003), and no significant hormone status x tone interaction (F(4,96) = 2.123, p = 0.0838). A ttest of average freezing across all 5 minutes of contextual recall confirmed that there were no
significant group differences (t(24) = 1.512, p = 0.1436; Figure 1G2).
These results indicate that there was no relationship between hormone status, as
measured by vaginal cytology, and cued or contextual fear recall. These results are somewhat
inconsistent with previous work (Jasnow et al., 2006a; Milad et al., 2009) illustrating hormone
status can influence aspects of auditory fear conditioning.
Acute systemic administration of citalopram enhances cued fear memory in females but not
males.
We tested whether an acute injection of the SSRI citalopram (10mg/kg or 20mg/kg, i.p.)
or saline (i.p.) administered prior to fear conditioning differentially affects fear learning in male
and female mice. Mice of each sex underwent fear conditioning (Figure 2A) in cohorts balanced
for citalopram (n=14/sex/dose) and saline exposure (n = 28). Saline animals have been collapsed
into one group for analysis. In females, there was no effect of drug group (citalopram vs. saline)
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on fear acquisition across all tones (F(2,53) = 1.150, p = 0.3245; Figure 2B1). There was a
significant effect of tone (F(4,212) = 400.9, p < 0.0001), but no drug group x tone interaction
(F(8,212) = 0.5722, p = 0.7960). Data for the 10 CS tones presented during cued recall are grouped
in 2-tone bins. During recall, citalopram dose-dependently elevated freezing behavior to CS
presentation in females (F(2,53) = 8.020, p = 0.0009; 2B2). There was a significant effect of tone
presentation (F(4,212) = 81.37, p <0.0001) and a significant tone x drug interaction (F(8,212) =

♀

♂

Figure 2. Acute systemic citalopram administration prior to fear conditioning enhances fear response in females only.
(A) Fear conditioning timeline. Citalopram 10mg/kg or 20mg/kg or saline was administered (i.p.) 60 min prior to
conditioning. (B1 & C1) Acute citalopram had no impact on freezing across 5 CS-US presentations. (B2) Citalopram
treatment caused a dose-dependent increase in freezing behavior twenty-four hours after acute injection and training,
indicating elevations in 5-HT availability can enhance cued fear learning. (B3 & C3) Citalopram did not alter contextual fear
recall. (C2) Citalopram did not significantly enhance fear learning in males although there is a trend for elevated freezing in
the 20mg/kg treatment group during the first bin. Acute citalopram resulted in decreased baseline levels of freezing in recall
context compared to saline males. Data presented as mean + SEM. *** p < 0.0005
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3.368, p = 0.0012). Twenty-four hours later contextual recall was tested and analysis of average
freezing during the entire five minutes revealed no significant effect of citalopram (ANOVA,
F(2,53) = 1.617, p = 0.2082; Figure 2B3).
In males, there were no group differences between mice given either dose of citalopram
(n = 14/dose) or those given saline (n = 28) across all tones during acquisition (F(2,53) = 0.3160, p
= 0.7304; Figure 2C1). As expected there was a significant elevation in freezing with additional
CS-US pairings (F(4,212) = 312.8, p < 0.0001), but no group x tone interaction (F(8,212) = 0.9299, p
= 0.4927). During recall twenty-four hours later, there was no effect of citalopram on freezing
behavior across all 10 tones (F(2,52) = 1.053, p = 0.3564; Figure 2C2), but there was a significant
effect of tone (F(4,208) = 66.46, p <0.0001) and a significant group x tone interaction (F(8,208) =
2.632, p = 0.0091). Analysis of the first CS-bin revealed that males given 20mg/kg citalopram
tended to freeze more than those given 10mg/kg (p = 0.0594) and those given saline (p =
0.0781). Notably, there is a group difference in pre-CS freezing during recall (F(2,52) = 12.72, p
<0.0001) with saline treated males freezing more than those given the low dose (10mg/kg) (p =
0.0002) and or high dose of citalopram (20mg/kg) (p = 0.0010). We detected no difference
citalopram groups in pre-CS freezing (p = 0.8829). No group differences in freezing during
context recall were identified (F(2,53) = 0.8557, p = 0.4308; Figure 2C3).
Acute systemic administration of citalopram reduces baseline freezing levels in males.
Unexpectedly, citalopram decreased freezing levels in the recall context, prior to CS
presentation in males (Figure 3A). This led us to more closely examine pre-CS freezing in the
recall context. To visualize how differences in pre-CS freezing may influence freezing during CS
presentation, pre-CS freezing for each animal was subtracted from freezing during each CS
presentation (Figure 3B). This results in an artificial citalopram-induced enhancement in fear
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learning. Analysis of this transformed data reveals a main effect of citalopram (F(2,52) = 7.605, p
=0.0013), an main effect of tone (F(4,208) = p<0.0001) and a significant citalopram x tone
interaction (F(8,208) = 2.632, p = 0.0091). As this technique relies on subtracting a single baseline
measure across multiple cued responses it must be interpreted with skepticism.
We tested whether group differences in pre-CS freezing are maintained throughout the
recall test by giving a difference cohort of males acute citalopram treatment prior to fear

Figure 3. Acute citalopram treatment enhances baseline fear response in the recall context in males. (A) Saline
(n = 28) treated males exhibit enhance baseline freezing behavior in the recall context prior to CS onset compared to
both 10mg/kg (n = 14), and 20mg/kg (n = 14) treated groups. (B) Transforming CS-induced freezing response by
subtracting baseline freezing level reveals an artificially enhanced fear response in citalopram treated animals. (C1) A
new cohort of males were treated with saline (n = 9), 10mg/kg (n = 7), or 20mg/kg (n = 9) 60 min prior to fear
conditioning with 5 CS-US presentations. (C2) During recall, no tones were audibly played. Saline animals exhibit
elevations in freezing at baseline and during initial ‘CS presentation’ but this difference disappears by the second bin,
suggesting that subtracting baseline freezing from cued data is not an accurate behavioral representation. (C3)
Citalopram had not effect on contextual fear recall. Data presented as mean + SEM. **p < 0.005 ***p<0.0005

conditioning and testing them in the recall box without any tone presentations. As before, there
were no differences between mice given saline (n = 9), 10mg/kg citalopram (n = 7), or 20mg/kg
citalopram (n = 9) during acquisition (F(2,22) = 1.043, p = 0.3691; Figure 3C1). There was an
expected effect of tone (F(4,87) = 239.5, p <0.0001) and no citalopram x tone interaction (F(8,87) =
0.2631, p = 0.9760). When mice were placed in the recall box, we scored freezing behavior
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during the time that tones are usually presented and found a significant effect of citalopram
(F(2,22) = 7.731, p = 0.0029; Figure 3C2), along with a significant effect of ‘tone’ (i.e. time)
(F(5,110) = 10.32, p < 0.0001) and a significant citalopram x ‘tone’ interaction (F(10,110) = 6.136, p
<0.0001). Multiple comparisons revealed that saline treated animals in this experiment froze
significantly more at baseline than the 10mg/kg (p < 0.0001) and 20mg/kg (p < 0.0001)
citalopram groups. Saline treated animals also froze significantly more during bin-1 than
10mg/kg (p = 0.0095) and 20mg/kg (p = 0.0017) citalopram groups. When tested for contextual
recall, there was no group effect (F(2,22) = 0.3929, p = 0.6798; 3C3). These findings suggests that
although citalopram treatment decreases pre-CS freezing, group differences do not persist during
the time that tones are normally presented. Collectively, these findings suggest that citalopram
may decrease generalization of fear from the training context to the testing context without
affecting recall of the training context. These findings warrant further investigation.
Acute systemic citalopram administration prior to fear conditioning enhances c-Fos
expression in the BNST and CeA in females.
Previous work demonstrated that acute SSRI treatment prior to fear conditioning in male
rats led to an upregulation of IEG activity within the adBNST and CeA but not the BLA – a
region required for auditory fear conditioning (Pelrine et al., 2016; Ravinder et al., 2013). To test
whether there are sex differences in this cellular response to an SSRI, we gave male and female
mice an acute injection of a low dose of citalopram (10mg/kg) or saline, fear conditioned them,
and perfused them 90 minutes later (Figure 4A, n = 7-8/group). Brains were analyzed for c-Fos,
a commonly used IEG. There were no significant group differences during fear conditioning
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Figure 4. Acute systemic citalopram upregulates c-Fos activity in the adBNST in females only. (A) Timeline of experiment.
(B) Fear conditioning data for 10mg/kg and saline treated males and females shows there were no significant group differences
during fear conditioning (n = 7 except male 10mg/kg citalopram n = 8). (C) Images of c-Fos + cells (green) in the three
subdivisions of the adBNST – ovBNST, alBNST, amBNST – in all groups tested. (D1) Example of adBNST subdivisions where
c-Fos + reactivity was quantified, adapted from Paxinos & Franklin. Females treated with citalopram exhibit an upregulation in
c-Fos + cells in the ovBNST (D1) and alBNST (D2) but not the amBNST (D3). (E) Images of c-Fos + cells in the CeA and BLA
in all groups tested. (F1) Example of amygdala regions where c-Fos + reactivity was quantified, adapted from Paxinos &
Franklin. Drug treatment significantly influenced c-Fos+ activity in the CeA and there is a significant drug x sex interaction (p =
0.007). (F2) Citalopram did not influence activity in the BLA but there was a significant sex effect. Data presented as mean +
SEM. *p < 0.05 **p < 0.005 ***p<0.0005
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(F(3,25) = 0.1036, p =0.957; Figure 4B) but as expected there was a significant effect of tone
(F(4,100) = 316.2, p < 0.0001).
We analyzed c-Fos reactivity in the three subdivisions of the adBNST – the ovBNST,
amBNST, and alBNST (Dong & Swanson, 2004a; M. Lebow & Chen, 2016), the CeA, and the
BLA. In the ovBNST, citalopram significantly increased c-Fos activity (F(1,24) = 7.852, p =
0.0099; Figure 4C - D1) but there was no effect of sex (F(1,24) = 2.988; p = 0.987) or citalopram
x sex interaction (F(1,24) = 1.581, p = 0.2207). Similarly, in the alBNST, there was a significant
effect of citalopram (F(1,24)=10.50, p = 0.0035; Figure 4C, D2), but no effect of sex (F(2,24) =
2.992, p =0.0965) or citalopram x sex interaction (F(1,24) = 1.827, p = 0.1891). Within the
amBNST, there was no significant effect of citalopram (F(1,24) = 3.891, p =0.0602; Figure 4C,
D3), sex (F(1,24)=1.321, p =0.2618), or citalopram x sex interaction (F(1,24) = 0.1122, p =0.7406).
Analysis of c-Fos levels in the CeA revealed a significant effect of citalopram (F(1,23) =
19.29, p = 0.0002; Figure 4E – F2) and a significant citalopram x sex interaction (F(1,23) = 8.622,
p = 0.0074), but no main effect of sex (F(1,23) = 1.145, p = 0.2958). Females treated with acute
citalopram had elevated c-Fos activity compared to saline-treated females (p = 0.0003).
Interestingly, saline treated females exhibited less c-Fos reactivity in the CeA than saline-treated
(p = 0.0475) and citalopram-treated males (p = 0.0036), indicating conditioning had a greater
effect on cellular activity in males than females. Within the BLA, there is an overall effect of sex
0.9489) or citalopram x sex interaction (F(1,23) = 0.00154, p =0.9744). The citalopram-induced
upregulation of c-Fos activity in the ovBNST, alBNST, and CeA that we find across sexes is
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Figure 5. Acute citalopram administration alone does not significantly influence c-Fos activity in the adBNST or amygdala.
(A) Timeline of acute systemic drug administration and perfusion. (B) Example of adBNST subdivisions where c-Fos + reactivity
was quantified, adapted from Paxinos & Franklin. Acute 10mg/kg citalopram did not influence c-Fos however males exhibited a
near significant increase in c-Fos in the (C1) ovBNST, (C2) alBNST and (C3) amBNST. (D) Example of amygdala subdivisions
where c-Fos + reactivity was quantified. Acute 10mg/kg citalopram did not influence c-Fos activity in the (E1) CeA or (E2) BLA.

similar to the pattern of IEG activity seen in previously (F(1,23) = 8.536, p = 0.0077; Figure 4E,
F3) but no effect of citalopram (F(1,23) = 0.00419, p = in male rats (Pelrine et al., 2016; Ravinder
et al., 2013).
It is well established that fear conditioning alone upregulates IEG activity in our regions
of interest. To distinguish between c-Fos activity induced by fear conditioning, citalopram, and
the combination of the two, we quantified c-Fos activity in the adBNST and amygdala in the
absence of fear conditioning (naïve) in mice of both sexes. Animals received either acute
systemic citalopram treatment (10mg/kg) or saline and were returned to their home cage for 160
min until they were perfused (Figure 5A, n = 4 all groups). In the ovBNST there was not a
significant effect of citalopram treatment (F(1,12) = 0.01672, p = 0.8993; Figure 5C1) or a
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citalopram x sex interaction (F(1,12) = 0.9613, p = 0.3462), but a near significant effect of sex
(F(1,12) = 4.560, p = 0.0540) on c-Fos activity. In the alBNST there was no effect of citalopram
treatment (F(1,12) = 0.5706, p = 0.4646; Figure 5C2) or citalopram x sex interaction (F(1,12) =
0.2121, p = 0.6533) but again we found a near significant effect of sex (F(1,12) = 4.574, p =
0.0537). A similar pattern was evident in the amBNST where there was no effect of citalopram
treatment (F(1,12) = 10.04, p = 0.0004; Figure 5C3), or a citalopram x sex interaction (F(1,12) =
0.1680, p = 0.6891) but a near significant effect of sex (F(1,12) = 4.347, p = 0.0591). Overall there
was a trend for greater c-Fos activity in males. Acute treatment with the SSRI citalopram
(10mg/kg) did not significantly alter c-Fos in this region in either males or females. This finding
suggests males may have greater baseline neural activity in the adBNST than females.
We next analyzed c-Fos activity within the CeA which revealed no significant effect of
citalopram treatment (F(1,12) = 1.1003, p = 0.3150; Figure 5E1), sex (F(1,12) = 0.0334, p = 0.8580),
or a citalopram x sex interaction (F(1,12) = 1.234, p = 0.2883). In the BLA there was also no
significant effect of citalopram treatment (F(1,12) = 0.4344, p = 0.5223; Figure 5E2), sex (F(1,12) =
0.7979, p =0.3893) or a citalopram x sex interaction (F(1,12) = 0.4398 p = 0.5198). Within the
amygdala acute systemic citalopram treatment, unassociated with fear conditioning, does not
significantly alter c-Fos activity.
DISCUSSION
We found that there was no relationship between hormone status, determined by vaginal
cytology, and fear conditioning in female mice. This was true when animals were grouped by
estrous cycle on the day of conditioning and when they were grouped by cycle status on the day
of the retrieval test. We then identified a sexually dimorphic response to acute systemic
administration of the SSRI citalopram prior to fear conditioning. Only females exhibited a dose-
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dependent enhanced fear response to tones when tested twenty-four hours after conditioning.
There was no effect of acute citalopram administration on contextual fear recall in either males
or females. Surprisingly, citalopram treatment reduced baseline freezing to the recall context in
males. Acute 10mg/kg citalopram treatment prior to fear conditioning upregulated the IEG
marker c-Fos in the ovBNST, alBNST, and CeA of females.
Estrous cycle monitoring was completed to determine if hormone status could influence
freezing behavior. In human fear conditioning studies, high estradiol levels are associated with
greater BOLD signal in the amygdala during fear conditioning in healthy cycling women,
suggesting hormones may influence fear learning (Hwang et al., 2015). Preclinical research
using naturally cycling female rats identified proestrus, characterized by high estradiol and
progesterone, as causing enhanced extinction recall, but there was no impact on initial cued fear
response (Milad et al., 2009). As our fear learning paradigm is not designed to address extinction
recall, it is not clear if we would have found a significant effect of hormonal status on this
measure. Other preclinical studies rely on pharmacological manipulation of hormone status. For
example, enhanced freezing during cued recall is seen in females with elevated estradiol levels
across several days when these animals are ovariectomized and estradiol is administered over
several days prior to conditioning (Jasnow et al., 2006). We used only freely cycling females in
our experiment, which may account for why our results differ from work relying on hormonal
manipulation.
Analysis of fear behavior in our experiment relied exclusively on freezing levels. Despite
some evidence in the literature that female rats may exhibit an alternative ‘darting’ behavior in
response to fear conditioning (Gruene, Flick, Stefano, Shea, & Shansky, 2015), this behavior was
not evident in our mice. This may be due to a species difference between rats and mice. As we
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could not identify a clear effect of estrous cycle on fear learning, or an alternative fear response,
we did not analyze hormone status in later experiments and only measured freezing behavior.
Acute systemic citalopram administered prior to fear conditioning had a sexually
dimorphic effect on fear learning. Two doses of citalopram, 10mg/kg and 20m/kg, were given 60
min prior to conditioning. Females exhibited a dose-dependent enhancement in tone-evoked
freezing twenty-four hours after conditioning. Previous work indicates acute SSRI treatment
elevates freezing behavior during cued recall (Burghardt et al., 2007, 2004; Pelrine et al., 2016;
Ravinder et al., 2013), however this work was completed exclusively in male rats.
The lack of an SSRI associated response in male mice suggests that we may have also
identified a species difference between male mice on a C57BL/6J background and male rats.
There are known differences in metabolic enzymes in mice and rats, including within the
CYP2D and CYP2C families (Martignoni, Groothuis, & de Kanter, 2006) which are implicated
in SSRI metabolism (Probst-Schendzielorz, et al., 2015). It is also generally accepted that mice
have a ‘faster’ metabolism than rats (MacAvoy, Arneson, & Bassett, 2006), so it is likely our
10mg/kg citalopram dose administered 60 min before fear conditioning was removed from the
body faster than male rats given the same dose at the same time point.
We also tested contextual fear recall. Previous studies examining the effects of acute
SSRI treatment on contextual fear recall have had mixed results. Acute escitalopram
administration prior to contextual fear acquisition has been found to increase fear response
(Montezinho et al., 2010) and decrease contextual fear (Inoue et al., 1996) acquisition. These
previous studies solely focused on contextual fear conditioning, unlike our protocol which is a
cued task. Although we found no effect of citalopram on contextual fear learning in males or
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females, it is noteworthy that our protocol differed from those used in previous contextual fear
conditioning studies.
Blood plasma analyses in rats indicates an acute dose of 10mg/kg citalopram is
equivalent to a standard dose of ~25mg in humans (Bocchio et al., 2016), suggesting
translatability in drug administration between preclinical and clinical paradigms. Previous work
has explored how acute citalopram alters fear responding in healthy volunteers. An acute 20mg
dose of citalopram enhances the fear potentiated startle response to cued threats without altering
overall anxiety or baseline (non-cued) startle (Grillon et al., 2007). Other work indicates that an
acute 20mg dose of citalopram can increase facial fear recognition (Browning et al., 2007).
These clinical studies support a role for SSRI-induced elevations in 5-HT in enhancing fear
processing. Notably however, these studies did not explore sex differences following acute
citalopram treatment.
We found that acute 10mg/kg citalopram upregulated c-Fos activity in the female BNST
only. Females exhibited increased c-Fos in the ovBNST and alBNST following fear
conditioning. Examination of naïve females which received only saline or 10mg/kg citalopram
treatment but did not undergo fear conditioning failed to reveal a citalopram-induced
upregulation of c-Fos in any subdivision of the adBNST. When examining the adBNST of naïve
males there was also no evidence for citalopram-induced c-Fos activity. Interestingly, we found
that in all three subregions of the adBNST, naïve males had a near significant increase in c-Fos
activity compared to females. However, males do not exhibit increased c-Fos activity in the
adBNST following fear conditioning. Together this data indicate that acute citalopram and
conditioning in combination significantly elevates cellular activity within the adBNST of
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females only. This illustrates a sexually dimorphic cellular response in the adBNST to acute
systemic citalopram and fear conditioning.
Our analysis of c-Fos activity in the CeA following fear conditioning revealed an effect
of citalopram treatment, and a significant citalopram x sex interaction. Following conditioning,
control (saline) males exhibit greater c-Fos activity in the CeA than control females. This
suggests that conditioning, independent of SSRI treatment, alters c-Fos activity in this region in a
sexually dimorphic manner with males exhibiting greater c-Fos activity than females. Acute
citalopram administration does not meaningfully alter c-Fos activity in the male CeA when
administered prior to conditioning, or when administered to naïve animals. Citalopram treatment
does significantly elevates c-Fos activity in the CeA of females but only when administered prior
to conditioning. Again, we find that acute citalopram and conditioning in combination
significantly elevates cellular activity within the CeA of female mice. These findings are in
agreement with work identifying an upregulation of IEG activity in the BNST and CeA
following acute SSRI treatment and conditioning (Pelrine et al., 2016; Ravinder et al., 2013).
We found that acute citalopram administration had no significant effect on c-Fos activity
within the BLA in male and female mice. This was true for naïve animals and for those that
underwent fear conditioning. Interestingly, some work has shown that acute citalopram
administration alone can upregulate c-Fos activity in the BLA (Izumi, Inoue, Kitaichi,
Nakagawa, & Koyama, 2006) but that is not seen in our study. We do find that in this region
males exhibit greater c-Fos activity than females following conditioning. This is in agreement
with our findings in the CeA –saline-treated males exhibit greater c-Fos levels than saline-treated
females. Other studies have identified sex differences in neuronal activity in the amygdala. For
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example, in a contextual discrimination paradigm female mice exhibit greater c-Fos activity in
the BA following retrieval than males (Keiser et al., 2017).
Upregulation of c-Fos activity in both the adBNST and CeA, two nodes of the extended
amygdala, but not the BLA is intriguing. Although the CeA is heavily innervated by the BLA
(Ciocchi et al., 2010; Johansen et al., 2011; Miserendino et al., 1990; Wilensky et al., 2006) there
is also significant communication between the adBNST and CeA (Dong & Swanson, 2004a;
Goode & Maren, 2017; Gungor, Yamamoto, & Paré, 2015b; Yamauchi et al., 2018).
Interestingly, CeA projecting neurons within the adBNST are found within the ovBNST and
alBNST subdivisions (Gungor, Yamamoto, & Paré, 2015b; Yamauchi et al., 2018). Our c-Fos
findings indicate that in females, the adBNST, in addition to the CeA may play a significant role
in cued fear learning.
Unexpectedly we found that in males, acute citalopram administration prior to fear
conditioning decreased baseline, pre-CS freezing in the recall context twenty-four hours later.
We reanalyzed the behavioral data and subtracted this baseline freezing response from each toneevoked response. Interestingly, when analyzed in this way there appeared to be a dose-dependent
citalopram-induced increase in fear response. However, this transformation would assume that
the elevated baseline freezing was consistent throughout the recall test. To determine if saline
control animals maintain elevated freezing to the context throughout the recall context we
conducted a follow-up experiment. Males received either 10mg/kg or 20mg/kg citalopram, or
saline, prior to fear conditioning and mice were tested in the recall context without any tone
presentations. We scored freezing behavior during the times when tones are usually presented
and found that group differences did not persist aft the first two ‘tone’ presentations. Although
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other publications have presented findings by subtracting baseline behavior (Allsop et al., 2018),
we determined that in our experiment this data transformation is not appropriate.
It is unclear why acute citalopram administration in males prevents an elevation in
baseline freezing behavior. Citalopram did not affect contextual fear recall in males that were
extinguished to the tone, or in males that did not undergo extinction (our follow-up experiment),
suggesting that this finding is not due to an alteration in contextual fear learning. While the
decrease in pre-CS freezing seen in citalopram-treated males could be due to elevated anxiety,
previous studies report that acute SSRIs increase, rather than decrease, anxiety measures in male
rodents (Bagdy, Graf, Anheuer, Modos, & Kantor, 2001; Mombereau, Gur, Onksen, & Blendy,
2010). Alternatively this citalopram-induced behavior could be due to increased discrimination
ability. Interestingly, there is evidence that the BNST contributes to discrimination. Lesioning
the adBNST in rats prior to differential auditory fear conditioning where one cue is paired with a
shock (CS+) and the other is not (CS-) results in better discrimination between the CS+ and CS(Duvarci, Bauer, & Paré, 2009). Additionally these lesioned animals exhibit reduced contextual
fear responses, which is not what we found in our study. Further work using anxiety tests, such
as the open field or elevated plus maze, or a contextual fear discrimination paradigm, are needed
to better explain this finding.
Our data supports a sexually dimorphic response to acute citalopram administration on
fear learning. Females exhibit a dose-dependent increase in fear behavior which is absent in
males. Although there is a large body of literature indicating the BNST is not required for fear
conditioning (Davis et al., 1997; Lebow & Chen, 2016; Walker & Davis, 1997, 2002) c-Fos
activity within the adBNST and CeA suggests that in females these regions are recruited during
fear learning and could underlie an enhanced fear response. Our current data set relies on entirely
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on a systemic serotonergic manipulation. Greater 5-HT availability throughout the brain will
undoubtedly influence cellular activity in many brain regions which could have downstream
effects in the BNST or amygdala. Although our c-Fos data indicates an increase in cellular
activity in the adBNST and CeA, it is not clear if this is due to greater BNST-to-CeA
communication or some other mechanism. Future work is needed to determine how these regions
communicate during times of elevated 5-HT availability.
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CHAPTER THREE
Optogenetic Stimulation of Serotonin in the BNST Induces a Sexually Dimorphic Fear
Response in Mice
Fear conditioning is a well-characterized model of fear learning used to investigate the
underlying neural circuits. Rodent work using a cued fear conditioning paradigm has
successfully elucidated the brain regions necessary for fear learning. Work over several decades
has underscored a role for the basolateral amygdala (BLA) in fear acquisition and the central
nucleus of the amygdala (CeA) in acquisition and expression (Ciocchi et al., 2010; Doyère et al.,
2003; Johansen et al., 2010; Ledoux, 2000; LeDoux et al., 1990; Maren, 2001; Rogan et al.,
1997; Wilensky et al., 2006). As part of the extended amygdala, the bed nucleus of the stria
terminalis (BNST) was originally associated with anxiety-like behavior or innate fear states
(Asok et al., 2018; Davis, Walker, Miles, & Grillon, 2010; Walker, Miles, & Davis, 2009;
Walker, Toufexis, & Davis, 2003). The anterior BNST region is highly interconnected with the
CeA and is often the focus of anxiety and fear-research; increasingly, the anterodorsal (adBNST)
is specifically targeted (Bruzsik et al., 2021; Pelrine et al., 2016a; Ravinder et al., 2013a;
Yamauchi et al., 2018).
The adBNST alone consists of three major subregions – the oval (ovBNST), anterolateral
(alBNST) and anteromedial (amBNST) – along with the much smaller juxtacapsular region
(Dong & Swanson, 2004a; Gungor & Paré, 2016b; M. Lebow & Chen, 2016). The al- and
ovBNST subregions send dense GABAergic projections to the CeM, while the CeL sends
GABAergic projections back to the al- and ovBNST (Dong & Swanson, 2004a; Gungor & Paré,
2016a; M. Lebow & Chen, 2016). Optogenetically stimulating only CeA-projecting neurons
within the adBNST is sufficient to increase innate anxiety in the elevated plus maze (Yamauchi
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et al., 2018). Interestingly, optogenetic activation of 5-HT projections in the adBNST is
anxiolytic and 5-HT1A receptor dependent (Garcia-Garcia et al., 2017).
Previous research identified a role for the BNST in acquisition of contextual fear
conditioning (Sullivan et al., 2004; Zimmerman & Maren, 2011). Inactivation of the BNST
attenuates freezing to the context, but interestingly only when contexts have been associated with
delayed shock-onset (~9 Min) and not fast onset (~1 Min), suggesting that the BNST is not
necessary for imminent, or cued, threats but instead is important for delayed or environmental
threats (Goode, Acca, & Maren, 2020). Although the BNST is a sexually dimorphic structure
(Allen & Gorski, 1990; Hines et al., 1992; Toufexis et al., 2007) the majority of anxiety and fear
research utilizes males only. A recent exception illustrated a sex difference in contextual fear, in
which only males exhibited an upregulation of Arc+ neurons (an IEG marker) in CeA projecting
neurons within the alBNST (Urien, Stein, Ryckman, Bell, & Bauer, 2021). Interestingly,
excitotoxic lesions of the alBNST attenuated context fear expression in both sexes. This indicates
that although the alBNST contributes to contextual fear expression in both sexes, females may
utilize a different, non-CeA projection, from the alBNST, and that this distinct projection may be
responsible for augmenting context fear expression.
There is a growing evidence that the anterior region of the BNST may also contribute to
cued fear conditioning. In rodents undergoing a differential fear conditioning paradigm, BNST
lesions did not significantly impact freezing responses to CS+ presentations, but decreased
freezing responses to the CS- (Duvarci et al., 2009), suggesting a role for the BNST cued fear
discrimination. Recently, chemogenetic activation of GABAergic neurons in the adBNST during
fear conditioning or consolidation, resulted in enhanced response to cues and an upregulation of
IEG activity in a number of downstream regions associated with fear (i.e. PAG), although
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notably not the CeA (Bruzsik et al., 2021). In this study, further refined chemogenetic
manipulation identified activation of SOM+, but not CRF+, neurons as a major contributor to
enhancing fear consolidation in a cued fear memory paradigm.
Elevations in 5-HT availability following acute administration of SSRIs upregulates fear
responses when administration occurs prior to fear conditioning (Burghardt, Bush, McEwen, &
LeDoux, 2007; Pelrine et al., 2016; Ravinder et al., 2013). Additionally, the increase in
immediate early gene (IEG) activity in the adBNST and CeA implicated these regions in the
SSRI-induced enhancement of fear learning (Pelrine et al., 2016; Ravinder et al., 2013). Targeted
SSRI administration into the adBNST, but not the CeA, prior to fear conditioning also resulted in
an enhanced fear response (Ravinder et al., 2013), which could be blocked by intra-BNST
infusion of a 5-HT2C receptor antagonist (Pelrine et al., 2016a). Optogenetic stimulation of 5-HT
projections into the adBNST during fear conditioning enhanced cued and contextual fear
response (Marcinkiewcz, Mazzone, D’Agostino, Halladay, Hardaway, Diberto, et al., 2016b)
further supporting a role for the adBNST in fear learning during times of elevated 5-HT
availability.
We previously demonstrated a sexually dimorphic fear response to acute citalopram
treatment. Citalopram administration prior to fear conditioning led to enhanced retrieval of the
fear memory in a dose-dependent manner in females only. Citalopram dose (10mg/kg, i.p.)
administered prior to fear conditioning enhanced c-Fos expression in the al- and ovBNST in
females but not males. In conjunction with increased c-Fos expression in the BNST, citalopramtreated females also exhibited an upregulation of c-Fos in the CeA. Interestingly, in males
citalopram treatment reduced pre-CS freezing in the recall context, suggesting a possible role of
serotonergic signaling in contextual discrimination.
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To further characterize the role of 5-HT signaling in the BNST during fear learning, we
utilized optogenetics to alter 5-HT levels with regional and temporal specificity. During fear
conditioning, we optogenetically stimulated 5-HT terminals within the adBNST during each tone
presentation only. We found that females, but not males, exhibited an enhanced fear response
during CS-recall with no significant effect on acquisition. Interestingly we again found that in
males, serotonergic manipulation during conditioning resulted in decreased pre-CS freezing in
the recall context. Optogenetic 5-HT manipulation also upregulated c-Fos activity within the
ovBNST and CeA in females only. In vivo electrophysiology was used to further characterize
BNST-to-CeA communication during fear conditioning and optogenetic manipulation. We show
that in females serotonergic stimulation during conditioning increases high-gamma coherence
between the adBNST and CeA during early recall. These findings are in line with our previous
work highlighting a sexually dimorphic response to citalopram-induced changes in fear learning.
Furthermore, our data clearly demonstrates a contribution of the adBNST in fear circuitry during
times of elevated 5-HT availability.
METHODS
Animals
Approximately twelve week old male and female SJL-Tg (Tph2-COP4*H134R/EYFP)
5Gfng/J mice (C57 background) were utilized for behavioral experiments (Jackson Laboratory,
Bar Harbor, ME). In this mouse line the channelrhodopsin (ChR2) – enhanced yellow
fluorescent (EYFP) protein is directed to serotonin neurons by the TpH2 promotor of the BAC
transgene. In the dorsal and median raphe ChR2-EYFP+ neurons were exclusively TPH2+
(100% when quantified) and TPH2+ immunofluorescence colocalized with EYFP+ neurons
above 80% in raphe regions examined, confirming selective serotonergic identity of ChR2-
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EYFP+ neurons in this line (Zhao et al., 2011). Animals carrying the ChR2-EYFP protein
(ChR2+) and littermate controls (ChR2-) were group housed (n = 2 – 4) with food and water
available ad libitum. Animals were bred and housed at the Hunter College Animal Care Facility
where they were maintained in a temperature controlled room on a 12 hour light/dark cycle with
lights on 08:00-20:00. All procedures were approved by the Hunter College Institutional Animal
Care and Use Committee.
Surgery
Male and female ChR2+ and ChR2- animals were anesthetized with a 2% isoflurane and
oxygen mixture, mounted with flat head-bars in the stereotaxic frame (Kopf Instruments,
Tujunga, CA, USA) and maintained on 1.5% isoflurane and oxygen during the surgery. Animals
received dexamethasone (0.05mL, 1mg/mL, s.c.) and bupivacaine under the scalp (0.1mL,
5mg/mL, s.c.) at surgery onset. Body temperature was maintained at 37oC + 1oC (T-1000, CWE,
USA). The skull was leveled within 30µm using bregma and lambda coordinates as landmarks
prior to craniotomies. For optogenetic manipulation, male and female ChR2+ and ChR2- animals
were bilaterally implanted with fiber optics in the adBNST (AP = +0.25 – 0.35, LM = + 1.00,
DV = - 4.15). Fiber optics were constructed with ceramic ferrules (ThorLabs, Newton, NJ) or
were ordered precut (New Doon China). Fiber optics were secured with opaque C&B Metabond
(Parkell, Edgewood NY) and an additional layer of black dental cement (Teets, Co-Oral-Ite
Dental Mfg, USA).
For electrophysiological recordings animals were bilaterally implanted with fiber optics
attached to tungsten wire (California Fine Wire Comp., USA) in the adBNST (AP = +0.25 –
0.35, LM = + 1.00, DV = - 4.15) and the CeA (AP = -1.17, LM = + 2.4, DV = -4.4) also secured
with Metabond and black dental cement. Skull screws (000-120, Amazon) were secured over the
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frontal cortex (reference) and cerebellum (ground). All wires were connected to a 16-channel
custom built electronic interface board carrying an Omnetics connector (Neuralynx, Bozeman,
MT). Tungsten wires were gold-pinned (large, Neuralynx, Bozeman, MT) to the board and
reference and ground wires were soldered to their respective locations.
For the retrograde tracing experiment, a 10µL syringe (Hamilton, USA) was fitted with a
fine tipped glass capillary tube and lowered into the right adBNST (AP = +0.25 – 0.35, LM = 1.00, DV = - 4.15). 0.25µL Cholera Toxin Subunit B – Alexa Fluor 647 (Thermofisher
Scientific, Waltham, MA) was infused at a rate of 0.1µL/min (Stoelting, IL, USA) and left in
place for 7 min. The craniotomy was then closed with bone wax (Look, Surgical Specialties) and
skin was closed with nonabsorbable nylon suture (5-0, Butler Shein). All animals received
isotonic saline (0.25mL, s.c.) and carprofen for pain relief (0.08mL, 1mg/mL, i.p.) prior to
waking and recovered for at least 5 days before being used in behavioral experiments.
Optogenetic Stimulation
In ChR2+ and ChR2- animals, optogenetic stimulation of 5-HT terminals in the adBNST
involved delivery of 473 nm blue light (Laserglow, Toronto, Canada) at ~10mW power.
Stimulation occurred in 5 msec pulses at 20Hz (WaveForm 33500B, Keysight Tech, CO, USA)
based on previous work that optimized response of ChR2 in 5-HT neurons (Zhao et al., 2011).
This stimulation protocol has also been previously published in behavioral studies (Dugué et al.,
2014; Garcia-Garcia et al., 2017). During fear conditioning, stimulation occurred during each CS
presentation (5, 30sec presentations). In naïve (non-trained) animals, 30sec stimulation was
delivered 5 times at intervals that varied pseudorandomly between of 30 – 60 sec.
Fear Conditioning
Apparatus
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Mice underwent fear conditioning as previously described. All behavior and
electrophysiological data was recorded using an infrared OptiTrack camera and Neuromotive
software running in conjunction with Central (Blackrock Microsystems, Salt Lake City, UT,
USA). Electrophysiology data was collected using a 1Hz low-pass filter and sampled at 2kHz.
Timestamps of all stimuli were extracted from Central-generated NEV files in MATLAB.
Behavior was hand-scored for freezing, which was defined as cessation of all movement with the
exception of respiration (Velasco et al., 2019a).
Fear Conditioning Procedure
Animals were handled and habituated to tethering with fiber optic cables for 3 days, 5
min each, prior to behavioral testing. During fear conditioning, animals were moved from the
animal facility to the holding area a minimum of 60 min prior to the start of the experiment on
days 1 – 5. On days 1 – 2 animals were habituated to the training and recall contexts for 20 min.
During this time, mice were also habituated to tethering to the fiber optic and electrophysiology
systems. On day 3, animals underwent auditory fear conditioning with 5 conditioned stimulus
presentations (CS: 2kHZ tone, 85dB, 30s) co-terminating with an unconditioned stimulus (US:
0.7mA footshock, 2sec). The first CS-US pairing occurred 120sec after start of the trial. The
inter-trial interval was randomly generated by Med-PC script for each animal and ranged from
90 – 120 sec. On day 4, animals were placed in the testing chamber for 10 CS presentations with
an inter-trial interval that was randomly generated between 90 – 120 sec. The first CS occurred
at 120 sec after the start of the recall trial. On day 5, animals were placed in the conditioning
chamber for 5 min.
Immunohistochemistry
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Ninety minutes after conditioning, or optogenetic stimulation in naïve groups, mice were
deeply anesthetized with a mixture of ketamine (100mg/kg, i.p.) and xylazine (7mg/kg, i.p.) and
transcardially perfused with ice cold 1% PBS followed by 4% paraformaldehyde-PBS. Brains
were processed as previously described. Every 6th section containing the extended amygdala was
processed for c-Fos immunoreactivity as described in the second chapter. Sections were mounted
on electrostatic slides and cover slipped with ProLong Gold plus DAPI antifade mounting
medium (ThermoFisher Scientific, Waltham, MA, USA). BNST and CeA sections were imaged
using a Nikon A1 confocal microscope (Melville, NY, USA) and cell counting was done
manually using ImageJ.
Animals in the retrograde tracing experiment were perfused 10 days after unilateral
cholera toxin subunit B injection into the right adBNST and brains were processed as previously
described. Every 6th section containing the extended amygdala and raphe nuclei was processed
for EYFP activity to confirm ChR2-EYFP presence along with GAD65/67 and vGlut3 to identify
GABAergic and glutamatergic neurons respectively. Briefly, slices were washed in 1%PBS0.1%TritonX100 (PBST) then incubated in 10% normal donkey serum-PBST for 1 hour at RT
before incubating in rabbit anti-EYFP (1:500 get vendor), mouse anti-GAD65/67 (1:250, get
vendor), and guinea pig anti-vGlut3 (1:250, get vendor) in 1%normal donkey serum-PBST at
4oC for 48 hours. Slices were then washed in 1%PBS and incubated in secondary antibodies for
1 hour at RT, donkey anti-rabbit 488 (1:100, vendor), donkey anti-guinea pig Dylight 405
(1:100, vendor), and donkey anti-mouse 594 (1:200, vendor). Sections were mounted and cover
slipped with ProLong Gold antifade mounting medium (ThermoFisher Scientific, Waltham, MA)
before imaging.
Electrophysiology Analysis
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During fear conditioning, local field potentials were sampled at 2kHz with a low pass <
1kHz filter. Following all behavioral experiments animals were deeply anesthetized with a
mixture of ketamine (100mg/kg, i.p.) and xylazine (7mg/kg, i.p.). Electrical current was applied
to each channel (5mA, 25s) to generate an electrolytic lesion for placement confirmation of
tungsten wires in the BNST and CeA. Data was only analyzed from channels with confirmed
placement. 60Hz noise was removed from signal using scripts in the MATLAB Signal
Processing Toolbox (removeLineNoise_SpectrumEstimation). All signal underwent root-mean
square (rms) processing to minimize differences in signal strength between electrodes. Time
stamps of interest were extracted from NEV files generated during behavior and signal was
filtered using custom scripts for theta (4 – 12 Hz) or gamma (30 – 120 Hz) prior to processing.
Multitaper time-frequency cross spectrogram analysis was used to evaluate power during pre-CS
and CS presentations in adBNST and CeA electrodes (mtcsg, Harris & Mitra) in theta (FFT =
4096, window length = 2048, overlap = 1024) or gamma (FFT = 2048, window length = 500,
overlap = 480) signal. Coherence between ipsilateral adBNST and CeA electrodes was
determined using mscohere and previously listed windowing parameters in theta and gamma
bands. CS-induced signal was normalized to pre-CS data.
Statistics
Statistical analysis was performed using GraphPad Prism 9 (San Diego, CA, USA). All
data are expressed as mean + SEM. Significance was accepted for p < 0.05. Significant group
differences in levels of freezing across tones were determined using a repeated measures twoway ANOVA. Bonferroni’s test was used for multiple comparisons following repeated measures
two-way ANOVA of behavioral data with two groups; Tukey’s post hoc test was used with three
groups. Group means were compared using an unpaired two-tailed t-test or one-way ANOVA.
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Immunohistochemical data were analyzed with a two-way ANOVA and Tukey’s test for
multiple comparisons.
RESULTS
Optogenetic stimulation of serotonergic projections in the adBNST enhances cued fear
memory in females but not males.
We previously established that pretreatment with the SSRI citalopram enhanced cued
recall in females. We also identified upregulation of c-Fos activity within subregions of the
adBNST and CeA in fear conditioned animals given citalopram. To determine if increasing 5-HT
availability within the adBNST is sufficient to enhance fear learning we used a genetically
modified mouse line in which the excitatory channelrhodopsin-2 protein (ChR2) is expressed
only in serotonergic neurons (Figure 6B). Fiber optics were implanted above the adBNST to
deliver blue light (473nm) concurrent with CS presentations in the conditioning session (Figure
6A). In female mice optogenetic stimulation of 5-HT terminals in the adBNST during
conditioning did not influence freezing behavior (F(1,37) = 0.6383, p = 0.4294; Figure 6C1)
however there was a significant increase in freezing across tones (F(4,148) = 307.5, p<0.0001) but
no stimulation x tone interaction (F(4,148) = 1.212, p =0.3080). Tone-evoked freezing during recall
is presented as two-CS bins. During cued recall, ChR2+ females (n = 19) exhibit elevated
freezing compared to ChR2- controls (n = 20) (F(1,37) = 12.73, p = 0.0012; Figure 6C2). As
expected there was a significant effect of tone (F(4,148) = 81.26, p < 0.0001) but no stimulation x
tone interaction (F(4,148) = 2.168, p = 0.0754). No significant differences were seen between
ChR2+ and ChR2- controls during contextual fear recall (t(37) = 1.000, p = 0. 3238; Figure 6C3).
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In male mice, comparison of ChR2+ (n = 19) and ChR2- controls (n = 18) revealed that
optogenetic stimulation of 5-HT in the adBNST did not affect acquisition of fear conditioning
(F(1,35) = 0.3005, p = 0.58700; Figure 6D1). There was a significant effect of tone (F(4,140) =
197.1, p < 0.0001) and no stimulation x tone interaction (F(4,140) = 0.6698, p = 0.6140). During
cued recall, we found no effect of stimulation (F(1,35) = 0.2405, p = 0.6269; Figure 6D2). There is
an overall effect of tone presentation (F(4,140) = 60.60, p < 0.0001) but no stimulation x tone
interaction (F(4,140) = 1.213, p = 0.3078). Similar to our citalopram findings, we again find an
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Figure 6. Optogenetic stimulation of 5-HT terminals in the adBNST during conditioning enhances cued fear learning in
females but not males. (A) Timeline of experiment, optogenetic stimulation occurred in ChR2+ or ChR2- animals during tone
presentation on conditioning day only. (B) Section of ChR2+ animal highlighting ChR2-EYFP expression in 5-HT neurons of the
DRN and MRN. (C1) In females optogenetic stimulation during conditioning has no main effect on freezing behavior but there is a
significant effect of manipulation by CS. (C2) During cued recall optogenetic serotonergic manipulation elevates freezing in ChR2+
females compared to controls (C3) but there is no impact during contextual recall. In males, serotonergic manipulation does not
impact freezing behavior during conditioning (D1), cued recall (D2), or contextual recall (D3). ChR2- controls exhibit greater
freezing during baseline compared to ChR2+ males in the cued recall context. Data presented as mean + SEM. **p< 0.005
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effect of 5-HT on pre-CS freezing behavior in males during cued recall. Here ChR2- controls
exhibit more freezing during baseline than ChR2+ males (t(35) = 3.388, p = 0.0018). There is no
significant difference between ChR2+ and ChR2- animals during contextual recall (t(35) = 1.057,
p = 0.2976; Figure 6D3). Together these results highlight a sexually dimorphic response to
optogenetic stimulation of 5-HT terminals in the adBNST.
Optogenetic manipulation of 5-HT terminals in the adBNST in males reduces pre-CS
freezing in the recall context.
We again found evidence that 5-HT for alters pre-CS freezing behavior in male mice.
Prior to the first CS presentation in the recall context, ChR2- controls freeze significantly more
than ChR2+ males (t(35)= 3.388, p = 0.0018; Figure 7A).Unlike baseline freezing behavior in the
citalopram experiment, here freezing levels in the ChR2- group at first glance appear highly
variable. The D’Agostino test for normality revealed the data do differ from a Gaussian
distribution (K2 = 7.520, p = 0.0233). Reanalyzing cued freezing behavior by subtracting pre-CS
freezing from CS-induced freezing reveals a significant effect of serotonergic manipulation on
behavior (Figure 7B). ChR2+ males (n =19) exhibit more freezing than ChR2- controls (n = 18)
(F(1,35) = 12.96, p = 0.0006) and there is a main effect of tone presentation (F(4,140) = 60.60, p <
0.0001) but no. stimulation x tone interaction (F(4,140) = 1.213, p = 0.3078). This data
transformation assumes elevated pre-CS freezing is maintained throughout the entire recall
session.
To determine if non-cued freezing behavior remains elevated, we repeated the experiment
in a different cohort of males (ChR2-, n = 10) but did not present any tones during the recall test
(Figure 6A). Timestamps generated by Med-PC were used to identify times that each tone would
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normally be presented, at which point freezing was measured. During conditioning no group
differences were seen between ChR2-No Tone Recall (NTR) animals and males fear conditioned
in the previous optogenetics experiment (F(2,44) = 1.066, p = 0.3532; Figure 7C1). As expected
there is a significant effect of tone (F(4,176) = 224.5, p < 0.0001) and no stimulation x tone
interaction (F(8,176)= 0.4766, p = 0.8716). During recall, there is a main effect of group (F(2,44) =
12.89, p < 0.0001; Figure 7C2) with ChR2-NTR animals exhibiting less freezing behavior than
ChR2- males that received audible CS presentations. This indicates that baseline freezing
behavior is not consistently elevated throughout the entire recall session. During recall there is
also a main effect of tone (F(4,176)= 43.17, p <0.0001) and a tone x group interaction (F(8,176) =
5.230, p < 0.0001).

Figure 7. Elevated baseline freezing in control males is not sustained throughout the cued-recall testing session. (A)
Control ChR2- males exhibit elevated baseline freezing levels compared to ChR2+ males prior to CS presentation in the
cued recall context. (B) Transforming cued behavior by subtracting baseline freezing results in a significant increase in fear
learning in ChR2+ males compared to controls. (C1) ChR2- No Tone Recall (NTR) males will undergo fear recall without
auditory CS presentations. They exhibit similar freezing patterns compared to ChR2- and ChR2+ males during optogenetic
stimulation concurrent with conditioning. (C2) ChR2-NTR males exhibit elevated baseline freezing behavior compared to
ChR2+ males. During CS ‘presentation’ ChR2-NTR males exhibit decreasing freezing compared to other groups indicating
elevated baseline behavior is not sustained throughout the testing period. (C3) ChR2-NTR males exhibit similar freezing
during contextual recall compared to males which underwent auditory cue extinction. Data presented as mean + SEM.
*p<0.05 ****p<0.0001
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Interestingly, analysis of freezing behavior in the absence of tone during recall revealed a
significant group effect (F(2,44) = 9.314, p = 0.0035), but ChR2-NTR did not significantly differ
from ChR2- (p = 0.2126) or ChR2+ males (p = 0.4077) across the whole trial. During contextual
fear recall, no difference in freezing behavior is seen between ChR2-NTR males and males that
underwent cued extinction (F(2,44) = 0.6547, p = 0.5246; Figure 7C3). The finding that control
males do not exhibit upregulated freezing throughout the cued recall test in the absence of CS
presentations suggests that it is not appropriate to subtract baseline freezing from freezing
exhibited during each tone presentation. Future experiments are needed to determine if
differences in baseline freezing behavior are due to effects of 5-HT on contextual fear
discrimination and/or anxiety-like behavior.
The number of serotonergic neurons projecting to the adBNST does not differ between
males and females.
Serotonergic neurons are located along the midline of the brainstem with a more
serotonergic neurons projecting to the amygdala and extended amygdala from the dorsal raphe
nucleus (DRN) than the median raphe nucleus (MRN) (Linley, Olucha-Bordonau, & Vertes,
2017). As there is evidence for sexual dimorphism in serotonergic communication (Dominguez,
Cruz-Morales, Carvalho, Xavier, & Brandao, 2003; Mitsushima et al., 2006), we quantified the
number of TpH2+ neurons projecting to the adBNST from raphe nuclei to determine if sexual
dimorphism in this projection may contribute to our findings. Male and female ChR2+ mice
received a unilateral injection of retrograde Cholera Toxin Subunit B (CTB), and the number of
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Tph2-ChR2+ neurons (ChR2 containing 5-HT neurons) colocalizing with CTB were quantified
(Figure 8A). Three male animals were excluded due to mistargeted CTB injections.
We found that within the DRN there is not a significant difference in the number of 5-HT
adBNST projecting neurons between males (n = 2) and females (n = 4), although there is a trend
for more adBNST projecting neurons in males (t(4) = 2.529, p = 0.0647; Figure 8B). There is also
no sex difference in the percentage of CTB neurons that are 5-HT+ in the DRN (t(4) = 0.5971, p =
0.5826; Figure 8C). Within the MRN there is no sex difference in the number of 5-HT projection
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Figure 8. There are no significant sex differences in the number of serotonergic adBNST-projecting neurons in
the DRN or MRN. (A) Section of DRN and MRN containing serotonergic (TpH2-ChR2+) and adBNST projecting
(CTB+) neurons. (B) In the DRN there are no significant sex differences in the number of TPH2 & CTB+ neurons or (C)
in the percentage of CTB+ neurons that are also TPH2+. (D) There are no significant sex differences in the number of
TPH2 & CTB+ neurons in the MRN or (E) in the percentage of CTB+ neurons that are also TPH2+. Data presented as
mean + SEM.

neurons to the adBNST (t(4) = 0.2211, p = 0.8358; Figure 8D) nor is there a difference in the
percentage of CTB neurons overall that are 5-HT positive (t(4) = 0.4771, p = 0.6582; Figure 8E).
We also analyzed the raphe for GAD65/67 and vGlut3 positive neurons to determine if
raphe projection neurons to the adBNST were also GABAergic or glutamatergic. Although there
was evidence of vGlut3 and 5-HT co-localization, these neurons were not CTB+ suggesting that
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projections to the adBNST are solely serotonergic. For more conclusive results, sample size must
be increased.
Optogenetic stimulation of serotonergic projections during fear conditioning enhances cFos activity in the BNST and CeA of females.
We previously found that acute citalopram administration prior to fear conditioning
upregulated c-Fos IEG activity within the adBNST. To determine if optogenetically stimulating
5-HT within the BNST during conditioning also upregulated c-Fos activity in a sexually
dimorphic manner, we perfused a cohort of male and female ChR2- and ChR2+ mice 90 min
following conditioning with optogenetic stimulation (Figure 9A). During conditioning there was
no significant difference in freezing between group (n = 4 – 6) (F(3,17) = 0.8742, p = 0.4738;
Figure 9B). As expected there was a significant effect of tone (F(4,68) = 161.4, p < 0.0001) but no
significant tone x group interaction (F(12, 68) = 0.04923, p = 0.9124). We quantified c-Fos in three
subregions of the adBNST – the ovBNST, alBNST and amBNST (Figure 9C). Our analysis of
the ovBNST revealed a significant effect of stimulation on c-Fos (F(1,17) = 4.548, p = 0.0478;
Figure 9D1), but no significant sex (F(1,17) = 1.563, p = 0.2281) or stimulation x sex interaction
(F(1,17) = 1.543, p = 0.2310). ChR2+ females demonstrated more c-Fos reactivity in this region
compared to control ChR2- females (p = 0.0491). Within the alBNST there was no effect of
serotonergic stimulation (F(1,17) = 1.453, p = 0.2446; Figure 9D2) and no sex (F(1,17) = 0.6771, p =
0.4220) or stimulation x sex interaction (F(1,17) = 0.5191, p = 0.4810) effect, which is dissimilar
to our c-Fos findings in the acute citalopram experiment. In the amBNST we found no effect of
serotonergic stimulation (F(1,17) = 0.7084, p = 0.4116; Figure 9D3), sex (F(1,17) = 0.00334, p =
0.9546) or a stimulation x sex interaction (F(1,17) = 0.6534, p = 0.4301).
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Figure 9. Stimulation of serotonergic projections during conditioning upregulates c-Fos activity in the ovBNST and CeA
of females. (A) Timeline of experimental protocol. (B) There was no significant effect of sex or serotonergic manipulation on
freezing behavior during conditioning. (C) C-Fos levels were analyzed in three subregions on the adBNST: ovBNST, alBNST,
& amBNST. (D1) In females serotonergic stimulation during conditioning upregulates c-Fos in the ovBNST. Within the (D2)
alBNST and (D3) amBNST there was no effect of serotonergic stimulation or sex. (E – F1) Serotonergic manipulation increased
c-Fos levels in the CeA and there was a significant sex x serotonergic manipulation interaction, p = 0.009. There were no
significant differences in c-Fos activity in the (F2) BLA. Data presented as mean + SEM. *p<0.05
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We also analyzed c-Fos activity within the CeA and BLA (Figure 9E). Within the CeA
we identified a significant effect of 5-HT stimulation (F(1,17) = 5.880, p = 0.0267; Figure 9F2)
and a significant sex x stimulation interaction (F(1,17) = 8.600, p = 0.0093) but no main sex effect
(F(1,17) = 3.326, p = 0.0858). ChR2+ females had significantly more c-Fos activity within the
CeA than control ChR2- females (p = 0.0022) and greater c-Fos activity than ChR2+ males (p =
0.0216). Analysis of c-Fos activity of the BLA did not reveal a main effect of stimulation (F(1,17)
= 0.00085, p = 0.9276; Figure 9F3), sex (F(1,17) = 0.1332, p = 0.7197) or a stimulation x sex
interaction (F(1,17) = 0.3654, p = 0.5540). The increase in c-Fos activity within the ovBNST and
CeA of females undergoing 5-HT stimulation is a similar pattern to our findings in the acute
citalopram experiment.
We optogenetically stimulated 5-HT release in the adBNST and measures c-Fos activity
in the adBNST and amygdala in animals that did not undergo fear conditioning (naïve). This
enabled us to determine how optogenetic stimulation of 5-HT terminals influences c-Fos
expression independent of fear learning. Naïve animals (n = 4 all groups) had fibers bilaterally
implanted above the adBNST. Less than a week later animals were habituated to tethering for 5
minutes a day for three days. After habituation, animals underwent optogenetic stimulation and
90 min later and were perfused (Figure 10A). Our c-Fos analysis of the ovBNST revealed no
effect of optogenetic 5-HT stimulation (F(1,12) = 0.8791, p = 0.3669; Figure 10C1), sex (F(1,12) =
0.2827, p = 0.6047), or a stimulation x sex interaction (F(1,12) = 0.01524, p = 0.9038) on c-Fos
activity. In the alBNST we also found no effect of stimulation (F(1,12) = 1.935, p = 0.1894; Figure
10C2), sex (F(1,12) = 1.080, p = 0.3191), or a stimulation x sex interaction (F(1,12) = 1.431, p =
0.2547). We identified a similar pattern in the amBNST with no effect of stimulation (F(1,152) =
0.9046, p = 0.3603; Figure 10C3), sex (F(1,12) = 0.78978, p = 0.3917), or stimulation x sex

64

Figure 10. Optogenetic manipulation of serotonin in the adBNST does not upregulate c-Fos activity in this
region or the amygdala. (A) Outline of experimental procedure. (B) Example of adBNST subdivisions where c-Fos +
reactivity was quantified, adapted from Paxinos & Franklin. Optogenetic manipulation does not influence c-Fos
activity in the (C1) ovBNST, (C2) alBNST, or (C3) amBNST. (D) Example of amygdala subdivisions where c-Fos +
reactivity was quantified. Optogenetic manipulation of serotonin in the adBNST did not influence c-Fos activity in the
(E1) CeA. There was a near significant effect of adBNST serotonergic manipulation on decreased c-Fos activity in the
(E2) BLA. Data presented as mean + SEM. * p < 0.05

interaction (F(1,12) = 0.0883, p = 0.7714). Optogenetically stimulating 5-HT terminals in the
adBNST alone does not significantly alter c-Fos activity in either sex. Unlike our previously
conducted naïve experiment in which males and females received acute 10mg/kg citalopram
(Chapter 2) we found no trend for sex differences in c-Fos activity within the adBNST.
When analyzing c-Fos activity in the CeA of naïve animals we found no effect of
optogenetically stimulating of 5-HT terminals in the adBNST (F(1,12) = 2.415, p = 0.1461; Figure
10E1), sex (F(1,12) = 1.585, p = 0.2320) or stimulation x sex interaction (F(1,12) = 0.1365, p =
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0.7182). Interestingly, 5-HT stimulation in the adBNST significantly elevated c-Fos activity in
the BLA (F(1,12) = 8.165, p = 0.0144; Figure 10E2) but there was no significant sex (F(1,12) =
2.130, p = 0.1702) or stimulation x sex interaction (F(1,12) = 0.2324, p = 0.6384) in this region.
Serotonergic manipulation increases connectivity between the adBNST and CeA during
early recall in females.
Using in vivo electrophysiology, we recorded local field potentials in the adBNST and
CeA during fear learning to characterize how increased 5-HT availability influences long-range
neural communication in these regions. Coherence between the adBNST and CeA was analyzed

♀

Figure 11. In females optogenetic 5-HT stimulation in the adBNST increases coherence between the adBNST and CeA
during early recall. (A) Electrophysiology data analyzed from cued recall CS Bins 1 – 2 and is normalized to pre-CS signal.
(B) Coherence in gamma oscillations (40 – 120 Hz) between adBNST and CeA of ChR2- controls (grey) and ChR2+ females
(blue) during early recall . (C) ChR2+ females exhibit elevated coherence between the adBNST and CeA in high gamma (90 –
120Hz) but not in low gamma (40 – 90 Hz) or theta (4 – 12 Hz) oscillations. (D) There was no significant change in normalized
theta, low, or high gamma power in the BNST or (E) the CeA during early recall. Data presented as mean + SEM. *p<0.05
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♂

Figure 12. In males optogenetic 5-HT stimulation in the adBNST does not alter adBNST and CeA communication. (A)
Electrophysiology data analyzed from cued recall CS Bins 1 – 2 and is normalized to pre-CS signal. (B) Coherence in gamma
oscillations (40 – 120 Hz) between adBNST and CeA of ChR2- controls (grey) and ChR2+ animals (blue) during early recall.
(C) ChR2+ animals do not exhibit altered adBNST and CeA communication in theta (4 – 12 Hz), low (40 – 90 Hz) , or high
gamma (90 – 120Hz) bands. (D) There was no significant change in normalized theta, low, or high gamma power in the BNST
or (E) the CeA during early recall. Data presented as mean + SEM.

with the magnitude squared coherence estimate (mscohere, MATLAB) during 30 sec pre-CS and
30 sec CS time points in the gamma (40 – 120 Hz) and theta (4 – 12 Hz) signal. During early
recall in females (CS Bin 1 – 2; Figure 11A), there was increased adBNST and CeA coherence in
high gamma (90- 120Hz) in ChR2+ animals that underwent optogenetic 5-HT stimulation during
conditioning (t(14) = 2.501, p = 0.0254; Figure 11B - C). There was no significant change in
coherence in low-gamma (t(14) = 1.096, p = 0.2914) or theta (t(14) = 0.5382, p = 0.5989) bands.
We then analyzed normalized power spectra for signal in the adBNST and CeA using a multitaper time-frequency cross-spectrogram. Within the adBNST there was no significant effect of
optogenetic 5-HT stimulation within the female adBNST in theta (t(24) = 1.621, p = 0.1181;
Figure 11D), low gamma (t(24) = 0.07154, p = 0.9436), or high gamma (t(24) = 0.6779, p =
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0.5043) bands. Analysis of power within the CeA also revealed no significant effect of
stimulating 5-HT in the adBNST on normalized theta (t(18) = 0.2283, p = 0.8220; Figure 11E),
low gamma (t(19) = 0.9473, p = 0.3554), or high gamma (t(18) = 0.1213, p = 0.9048) power.
Local field potentials were also analyzed in males during early recall (Figure 12A).
Unlike females, coherence between the adBNST and CeA in high gamma was not affected by
optogenetically stimulating 5-HT in the adBNST during conditioning (t(16) =1.033, p = 0.3171;
Figure 12 B - C). There was also no effect on coherence in theta (t(15) = 1.337, p = 0.2010) or
low gamma (t(16) = 0.05541, p = 0.5872). Analysis of power within the adBNST during early
recall in males did not reveal an effect of 5-HT stimulation on theta (t(24) = 0.03133, p = 0.9753;
Figure 11D), low gamma (t(24) = 0.02262, p = 0.9821), or high gamma oscillations (t(24) =
0.03316, p = 0.9738). The same pattern was seen in analysis power spectra in the CeA. That is,
there was no effect of optogenetic stimulation in the adBNST on theta (t(17) = 0.01497, p =
0.9882; Figure 11E), low gamma (t(17) = 0.2766, p = 0.7854), or high gamma (t(17) = 0.2510, p =
0.8048). These findings highlight another sexually dimorphic response to stimulation of 5-HT
within the adBNST during conditioning – only females exhibit increased adBNST-CeA
synchrony in the fast high-gamma band during early cued recall.
Discussion
We utilized a mouse line containing the excitatory channelrhodopsin-2 exclusively in 5HT neurons in the CNS to evaluate how optogenetic 5-HT manipulation in the adBNST alters
fear learning. Using retrograde tracing, we did not detect a sex difference in the number of 5-HT
neurons projecting from the DRN or MRN to the adBNST. We did find that the majority of 5-HT
projections to the adBNST arise from the DRN in both sexes. Optogenetically stimulating 5-HT
projections to the adBNST during conditioning led to an enhanced fear response during recall in
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females, but not males, similar to what we found when 5-HT was increased throughout the brain
by acute citalopram administration. Interestingly, we again found that increases in 5-HT were
associated with reduced pre-CS freezing behavior in the recall context in males. A follow-up
experiment in which mice were tested without tone presentations revealed that this group
difference did not persist throughout the recall test session.
Post-conditioning IEG analyses revealed elevated c-Fos activity in females but not males
in the ovBNST and CeA. We also identified an interaction between sex and 5-HT stimulation in
the CeA. Analysis of local field potentials revealed that stimulation of 5-HT in the adBNST
during learning led to an increase in high-gamma coherence between the adBNST and CeA in
females but not males during early recall. Together these findings further support a sexually
dimorphic response to elevated 5-HT in the adBNST.
Previous work has shown that the adBNST receives a dense serotonergic projection from
the DRN, with only sparse input from the MRN (Asan, Steinke, & Lesch, 2013; Freedman &
Shi, 2001; Marcinkiewcz et al., 2016). To confirm the location of serotonergic projection
neurons in males and females, we unilaterally infused the retrograde tracer Cholera Toxin
Subunit B into the adBNST. In agreement with previous work, we find the majority of 5-HT
projections to the adBNST originate in the DRN with fewer coming from the MRN. Although
we did not identify a sex difference in the number of 5-HT neurons projecting to the adBNST,
our analysis is limited by the small number of male animals used (n = 2) as a result of off-target
injections. Increasing sample size will allow us to more precisely compare the number of 5-HT
neurons projecting to the adBNST in males and females. Previous work suggests that female
rodents exhibit greater 5-HT activity throughout the entire brain (Giulian et al., 1973; Rubinow
et al., 1998), and within the amygdala females exhibit greater 5-HT release following stress
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(Mitsushima et al., 2006). Follow-up experiments evaluating 5-HT release in the adBNST (i.e. in
vivo microdialysis) would provide insight into whether such sex differences exist in this region.
In both males and females, we failed to identify neurons projecting to the adBNST that
were glutamatergic or GABAergic despite the known presence of these neural types in the DRN
(McDevitt et al., 2014). That is, we did not identify co-expression of vGlut3 in 5-HT neurons
projecting to the adBNST. vGlut3 has been previously shown to influence 5-HT activity in other
regions, such as the nucleus accumbens (Liu et al., 2014). This suggests that manipulation of the
5-HT raphe projections to the adBNST specifically affects 5-HT, not glutamate neurotransmitter
release. Increasing the sample size will allow a more precise sex comparison in the number of 5HT neurons projecting to the adBNST. Although this technique allows us to quantify the number
of 5-HT neurons projecting to the adBNST it does not allow us to draw a conclusion about the
amount of neurotransmitter release.
To determine if elevated 5-HT availability in the adBNST alone is sufficient to enhance
fear learning in female mice, we optogenetically stimulated serotonergic projections into this
region with tone presentation during conditioning. Stimulation during conditioning did not alter
freezing behavior in males or females. However, twenty-four hours later during cued recall,
females that received 5-HT stimulation in the adBNST exhibited an enhanced fear response to
cue compared to control females. There was no effect of optogenetic stimulation of 5-HT in the
adBNST on fear recall in males. There was also no effect of optogenetic stimulation during
conditioning on contextual recall in males or females. These findings align with our previous
work in which acute citalopram administration enhanced fear recall in a sexually dimorphic
manner. Although we find no behavioral effect of 5-HT manipulation in males, our findings in
females are consistent with the pattern seen in previous research (Marcinkiewcz et al., 2016).
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In a separate cohort of animals, we analyzed c-Fos activity following fear conditioning
and found that 5-HT upregulated learning-induced c-Fos in the ovBNST and CeA in females.
This is consistent with previous work illustrating an upregulation of c-Fos in these regions after
local infusion of SSRI and conditioning (Ravinder et al., 2013), and is also consistent with our
previous findings that acute citalopram administration prior to conditioning upregulates c-Fos in
the adBNST and CeA in females. In animals that received 5-HT stimulation without training
(naïve) we found no significant effect of stimulation alone on c-Fos activity in the adBNST or
CeA. Our results imply that elevated 5-HT activity in the adBNST during conditioning impacts
neuronal activity in the CeA. Interestingly, we did find that 5-HT stimulation in the adBNST in
naïve animals was associated with an increase in c-Fos activity in the BLA in both sexes. Sparse
projections from the adBNST to the BLA have been previously identified, with the majority of
the projections originating in the small juxtacapsular subregion (Lebow & Chen, 2016). Given
the scant projections from the adBNST it is possible that our optogenetic stimulation of 5-HT in
the BNST elevated c-Fos activity in the BLA via a separate brain region.
Our analysis of c-Fos activity within the CeA following optogenetic stimulation and
conditioning revealed an effect of 5-HT stimulation, and a significant stimulation x sex
interaction, indicating our manipulation does not impact males and females uniformly. We
previously identified an interaction effect in CeA c-Fos activity in our acute citalopram
experiment (Chapter 2). Our findings indicate that sex influences how our 5-HT manipulation
alters c-Fos activity within the CeA, and suggests underlying sex differences within this region.
In females the increase in c-Fos in the adBNST and CeA following 5-HT stimulation suggests
the adBNST influences neuronal activity in the CeA. Studies have shown that anterior lateral
subregions of the BNST (such as the ov- and al-BNST) send more dense GABAergic projections
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to the CeA than other BNST subregions (Yamauchi et al., 2018), and that selective activation of
CeA projecting neurons in the BNST can alter anxiety-like behavior. Recent work examining
contextual fear conditioning found that male rats have elevated IEG activity in CeA-projecting
neurons in the alBNST following contextual fear expression (Urien et al., 2021).
Similar to what we found with acute citalopram administration, we again found that
optogenetic stimulation of 5-HT in the adBNST decreased pre-CS freezing on the day of recall.
We again conducted a follow-up experiment to determine if elevated pre-CS freezing behavior
remained high throughout recall task in the absence of tone presentations. After bilaterally
implanting control (ChR2-) males with fiber optics above the adBNST, they were conditioned
according to our standard protocol but during recall no tone presentations were audible. We
determined that increased pre-CS freezing did not remain high throughout the test period and
simply subtracting pre-CS freezing from CS-induced behavior would not be an accurate
representation of our data. Interestingly, Bruzsik et al. (2021) find that chemogenetically driving
GABAergic activity in the BNST during fear consolidation increases pre-CS freezing during
extinction recall. They explain their findings as impairments in contextual discrimination,
because animals exhibit elevated freezing behavior in the ‘safe’ recall context. The authors did
not explore possible alterations in innate anxiety (i.e. open field or elevated plus maze testing).
Follow-up experiments in males are needed to determine if our fear conditioning protocol is
elevating innate anxiety levels ,which are subsequently reduced by 5-HT manipulation within the
adBNST, or if we are affecting contextual fear discrimination.
We conducted in vivo analysis of adBNST and CeA communication during fear
conditioning by analyzing local field potentials in both regions. We identified an increase in
coherence between the adBNST and CeA during high gamma (90 – 120 Hz), but not low gamma
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(40 – 70 Hz) or theta (4 – 12 Hz) bands in females. Separate analyses of localized power in the
adBNST and CeA did not reveal a significant effect of 5-HT stimulation on theta, low gamma, or
high gamma oscillations. In males, 5-HT stimulation did not influence coherence or power in the
adBNST and CeA. It is important to note, our electrophysiology data is normalized to pre-CS
signal but control males (ChR2-) exhibit elevated pre-CS freezing. This may be impacting our
data making interpretation difficult. Previous work examining oscillations during a fear
discrimination paradigm demonstrates an increase in theta power (4 – 12Hz) in the BLA when
animals are presented with a shock-associated cue (CS+) in conjunction with elevated BLA-tomPFC theta coherence in animals during cue-discrimination (Likhtik et al., 2014). Other studies
have found that CS-evoked fear behavior is associated with elevated theta coherence across the
LA-hippocampus–mPFC network, and that this coupling decreases during extinction learning
(Lesting et al., 2011). Notably, due to limitations with our tracking system we analyzed data
during entire CS presentations instead of isolating time of CS-evoked freezing. Future analysis
will be conducted on data confined to periods of CS-induced fear behavior. Interestingly, we did
not find altered coherence between the adBNST and CeA in the theta band, which may reflect
differences between the extended amygdala and other fear circuits in fear memory retrieval. O
Our findings in gamma signal are consistent with previous conditioning studies. Using an
appetitive trace conditioning task, learning increased gamma power in the BLA and this
oscillation entrained neuronal firing in the rhinal cortex (Bauer, Paz, & Paré, 2007). Other work
has shown that during fear discrimination, slow and fast gamma oscillations in the BLA are
coupled to alternate phases of low theta oscillations (4 – 8 Hz) during fear recall (Stujenske,
Likhtik, Topiwala, & Gordon, 2014). This phenomena of cross-frequency coupling is also seen
in the hippocampus where theta oscillations entrain gamma signaling (Belluscio, Mizuseki,

73

Schmidt, Kempter, & Buzsáki, 2012). Future analyses will be conducted to determine if fast
gamma oscillations in the adBNST are coupled to theta.
Analysis of neuronal oscillations within the BNST during behavioral tasks have not been
extensively explored. One recent study analyzed oscillatory communication between the
adBNST and nucleus accumbens following chronic stress and found that stress increases
adBNST-to-accumbens synchrony in theta (4 – 12Hz), beta (12 – 30 Hz) and gamma ( 30 – 50
Hz) bands (Xiao et al., 2020). Our current data does not include analysis of beta signal, as this
oscillation has not previously been associated with fear learning. Studies analyzing other highfrequency oscillations (110 – 160 Hz) within the extended amygdala have found this signal to be
prominent during quiet wakefulness with high coherence between BNST and CeA recording
sites (Haufler & Pare, 2014). Our preliminary analysis did not identify a prominent highfrequency oscillation during conditioning. To our knowledge, our study is the first to analyze
local field potential recordings in the adBNST during retrieval of a cued fear memory.
Although previous work has primarily established a role for the BNST in modulating
anxiety-like behavior (Davis, Walker, & Lee, 1997; Walker & Davis, 1997; Walker et al., 2003)
more recent research strongly suggests a role for this region in fear learning. In vivo unit
recordings in the adBNST during cued conditioning identified two neuronal populations
responsive during acquisition (Bjorni, Rovero, Yang, Holmes, & Halladay, 2020). Another study
using a partially-reinforced fear paradigm (footshock is delivered with 50% of tones), identified
elevated c-Fos activity in the BNST and mPFC following conditioning. Chemogenetically
inactivating mPFC-to-BNST projections increased fear response during periods of uncertain
threat (Glover et al., 2020) denoting a role for the BNST in modulating fear behavior during
times of uncertainty. In male mice, chemogenetic activation of SOM+ neurons in the BNST
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during consolidation enhanced cued fear memory formation (Bruzsik et al., 2021). Bruzsik et al.,
(2021) used c-Fos activity to identify several downstream targets of SOM+ BNST neurons,
including the paraventricular nucleus of the hypothalamus, ventral tegmental area, and
ventrolateral periaqueductal gray. Interestingly, the CeA was not included in this list of
downstream targets.
Our data supports a sexually dimorphic response to elevated 5-HT availability in the
adBNST during fear conditioning such that females, but not males, exhibit increased freezing
during cued recall. They also exhibit a 5-HT dependent increase in c-Fos activity in the ovBNST
and CeA. During early recall, the adBNST and CeA exhibit elevated high gamma coherence,
which is not evident in males. Together this suggests that acute 5-HT elevations in the adBNST
may influence fear behavior via a BNST-to-CeA pathway in females but not males. Follow-up
analyses will further define in vivo BNST-to-CeA communication during fear conditioning.
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CHAPTER FOUR
Inhibiting Projections from the BNST to the Central Nucleus of the Amygdala Reduces
Cued and Contextual Fear Recall in Female Mice
The BNST, specifically the adBNST subregions, including the ovBNST, alBNST, and
amBNST, have only recently been identified as contributors to fear learning. In male rats, acute
SSRI infusion into the adBNST prior to fear conditioning enhanced fear response during cued
recall twenty-four hours later (Ravinder et al., 2013a). Optogenetic stimulation of 5-HT
projections to the adBNST increased cued and contextual fear recall in mice (Marcinkiewcz,
Mazzone, D’Agostino, Halladay, Hardaway, Diberto, et al., 2016). In vivo electrophysiological
recordings within the adBNST during fear conditioning has identified neurons responsive to CS
presentation during acquisition and recall tests (Bjorni et al., 2020; Haufler et al., 2013). Recent
work in male mice finds that chemogenetically activating GABAergic or SOM+, but not CRF+,
neurons in the BNST during consolidation elevates fear responses during cued recall (Bruzsik et
al., 2021). However, inhibition of these neurons does not significantly reduce fear responses
suggesting the BNST can enhance fear memory consolidation, but is not required for fear
learning.
The adBNST and CeA are highly interconnected structures. Projections from the
adBNST to the CeA clustered primarily in anterior lateral subdivisions – the ovBNST and
alBNST (Gungor & Paré, 2016b). In vitro manipulation of these projections results in inhibitory
post synaptic potentials (IPSPs) within CeA neurons. The majority of these projections are
directed to CeM neurons, although there are also inhibitory synapses within the CeL (Gungor,
Yamamoto, & Paré, 2015a). Activating projections from the adBNST to the CeA during
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behavior is anxiogenic, while activating projections from the adBNST to the VTA or LH does
not affect anxiety-like behaviors (Yamauchi et al., 2018).
The CeA also sends a dense projection to the adBNST with a high number of these
GABAergic projections terminating within the ovBNST. Disinhibition of these projections from
the CeL increases anxiety-like behavior in the elevated plus maze (Ahrens et al., 2018).
Optogenetically inhibiting only CRF+ CeL neurons projecting to the adBNST significantly
reduces context fear recall, indicating this projection can influence fear expression (Asok et al.,
2018), and not just anxiety states. In clinical studies, in vivo imaging identified increased BNSTto-CEA connectivity during negative affective responses, consistent with a role for this
connection beyond immediate threat (Pedersen et al., 2020).
Although the BNST is a sexually dimorphic structure (Allen & Gorski, 1990; Lebow &
Chen, 2016; Toufexis et al., 2007) analysis of sex differences in BNST-to-CeA communication
has been understudied and research examining sex differences in this circuit during fear learning
is limited. A notable exception is work on contextual fear conditioning by Urien et al., (2021) in
which they identify an upregulation of IEG activity within CeA-projecting neurons in lateral
adBNST subregions (alBNST and ovBNST) in males only. Interestingly, ibotenic acid lesions of
the BNST significantly reduced fear behavior during testing in both male and female rats
indicating this region is necessary for fear expression in of a contextual fear memory in both
sexes. Given that females do not exhibit increased c-Fos activity in CeA-projecting neurons, a
neural pathway outside of direct BNST-to-CeA communication may be necessary for generating
a fear response.
We previously established that acute citalopram administration (i.p.) prior to conditioning
elevated fear expression during recall and upregulated c-Fos activity within the adBNST and
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CeA in females. We then found that optogenetically stimulating 5-HT release in the adBNST
during conditioning enhanced fear expression, increased c-Fos activity in the ovBNST and CeA,
and upregulated coherence of high gamma oscillations between the adBNST and CeA in
females only. These results suggest that in females, elevating 5-HT availability in the adBNST
during auditory fear conditioning may enhance cued fear recall via a projection to the CeA. To
determine if BNST-to-CeA communication is necessary for mediating these effects we utilized a
combination of optogenetic and chemogenetic approaches. We injected a retrograde inhibitory
DREADD (designer receptor exclusively activated by designer drugs) into the CeA and
delivered clozapine-N-oxide (CNO) bilaterally into the adBNST to inhibit only CeA-projecting
neurons prior to fear conditioning. During conditioning, we optogenetically stimulated 5-HT
terminals in the adBNST according to parameters used in previous experiments. We found that
inhibiting adBNST neurons projecting to the CeA significantly reduced cued and contextual fear
recall regardless of 5-HT stimulation. The findings of this experiment strongly suggest that in
females, BNST-to-CeA communication is necessary for cued and contextual fear learning.
METHODS
Animals
Approximately thirteen week old female SJL-Tg (Tph2-COP4*H134R/EYFP) 5Gfng/J
mice (C57 background) (Jackson Laboratory, Bar Harbor, ME) were used in behavioral
experiments. In this mouse line, the channelrhodopsin (ChR2) – enhanced yellow fluorescent
(EYFP) protein is directed to serotonin neurons by the TpH2 promotor of the BAC transgene.
Animals carrying the ChR2-EYFP protein (ChR2+) and littermate controls (ChR2-) were group
housed (n = 2 – 4) with food and water available ad libitum. Animals were bred and housed at
the Hunter College Animal Care Facility where they were maintained in a temperature and

78

controlled room on a 12hour light/dark cycle with lights on 08:00-20:00. All procedures were
approved by the Hunter College Institutional Animal Care and Use Committee.
Surgery
About six-weeks before the start of behavioral experiments, females underwent bilateral
infusion of the inhibitory DREADD pAAV-hSyn-hM4D(Gi)-mCherry (Addgene, Watertown,
MA) or control virus pAAV-hSyn-EYFP (Addgene, Watertown, MA). ChR2+ and ChR2females were anesthetized, as previously described. Using a fine-pulled glass capillary tube
DREADD or the control virus was infused into the CeA (AP = -1.17, LM = + 2.4, DV = -4.4) at
0.1uL/min (Stoelting, IL, USA) with 10µL Hamilton syringes (Hamilton, USA) for a total
volume of 0.25uL/side. Following injection, the skull was closed with bone wax (Look, Surgical
Specialties) and nylon nonabsorbable sutures were used to close the incision (5-0, Butler Shein).
Approximately four weeks later, females underwent a second surgery to place a cannula above
the adBNST. This involved placing a custom cut bilateral cannula (P1 Technologies, VA, USA)
was placed above the adBNST (AP = +0.25 – 0.35, LM = + 1.00, DV = - 3.75 – 4.00) and
securing it using both opaque C&B Metabond (Parkell, Edgewood NY) and an additional layer
of black dental cement (Teets, Co-Oral-Ite Dental Mfg, USA). Dummy cannula were placed in
each cannula and all females recovered from surgery, as previously described.
Optogenetic Stimulation
In ChR2+ and ChR2- animals, optogenetic stimulation of 5-HT terminals in the adBNST
occurred via 473 nm blue light (Laserglow, Toronto, Canada) at ~10mW power. Stimulation
occurred in 5 msec pulses at 20Hz based on previous work optimizing response of ChR2 in 5-HT
neurons (Zhao et al., 2011). Cannula adapters for fibers (P1 Technologies, VA, USA) were
secured onto stripped fiber optic wire (200µm, Thorlabs, Newton, NJ). Prior to fear conditioning,
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fiber optics were carefully inserted into cannula and secured in place with a fiber cap (P1
Technologies, VA, USA). Optogenetic stimulation only occurred during each CS presentation
during training (5, 30sec presentations).
Fear Conditioning
Apparatus
Mice underwent fear conditioning in Med Associates (Fairfield, VT, USA) chambers and
a custom recall context using the parameters previously described. Auditory tones and foot
shocks were delivered via custom Med-PC scripts (Med Associates, Fairfield, VT, USA). All
behavior was recorded using an infrared OptiTrack camera and Neuromotive software running in
conjunction with Central (Blackrock Microsystems, Salt Lake City, UT, USA). Timestamps of
all stimuli were extracted from Central-generated NEV files in MATLAB. Behavior was handscored for freezing, which was defined as cessation of all movement with the exception of
respiration (Velasco et al., 2019a).
Fear Conditioning Procedure
Animals were handled and habituated to dummy cannula insertion for 5 minutes a day for
3 days. On the fourth day, animals were habituated to fiber optic tethering for 5 min each. On
behavioral testing days 1 – 5 animals were moved from the animal facility to the holding area a
minimum of 60 min before the start of the experiment. On days 1 – 2, animals were habituated to
the tethering to the fiber optic system and training and recall contexts for 20 min. On day 3,
animals received a 0.35uL bilateral clozapine-N-oxide (CNO, 1mM) infusion (GenieTouch, Kent
Scientific, CT, USA) into the adBNST at a rate of 0.1uL/min. The injection cannula (P1
Technologies, VA, USA) was held in place for an additional 5 min to ensure diffusion of CNO
from the tip of the cannula into surrounding tissue. Animals were then brought to the Med-PC
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conditioning chamber and tethered to the fiber optic system. Animals received 5 conditioned
stimulus presentations (CS: 2kHZ tone, 85dB, 30s) co-terminating with an unconditioned
stimulus (US: 0.7mA footshock, 2sec). The first CS-US pairing occurred 120sec after start of
training, then inter-trial interval was randomly generated by Med-PC script (90 – 120 sec). On
day 4, animals were placed in the testing chamber and were exposed to 10 CS presentations. The
first CS occurred at 120sec after start of the recall session and inter-trial intervals were randomly
generated (90 – 120 sec). On day 5, animals were placed back in the conditioning chamber for 5
min.
Statistics
Statistical analysis was performed using GraphPad Prism 9 (San Diego, CA, USA). All
data are expressed as mean + SEM and significance was defined as p < 0.05. Significant
differences between groups in freezing level across tones was determined using a repeated
measures two-way ANOVA followed by a Tukey’s post hoc test for multiple comparisons.
Freezing behavior during context recall was analyzed with a two-way ANOVA followed by a
Tukey’s post hoc test.
RESULTS
Inhibiting projections from the adBNST to the CeA during fear conditioning reduces cued
and contextual fear recall in females.
To determine if communication between the adBNST and the CeA is necessary for 5-HT
in the adBNST to enhance fear learning in female mice, we chemogenetically inhibited only
CeA-projecting neurons in the adBNST during training and optogenetically stimulated 5-HT
terminals in this region during CS presentation (Figure 13A-B). We utilized ChR2- and ChR2+
mice that received either inhibitory DREADD or control virus (ChR2-/EYFP n = 5; ChR2-
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Figure 13. Inhibiting CeA projecting neurons in the adBNST decreases cued and contextual fear responses in female
mice. (A) Combination optogenetic and chemogenetic scheme – retrograde hM4Di or control is injected into the CeA. CNO is
delivered via cannula to the adBNST prior to fiber optic insertion. (B) Timeline of experiment. CNO is delivered into the
adBNST prior to fear conditioning and optogenetic stimulation of 5-HT terminals in this region occurs in ChR2+ and ChR2animals during CS presentations. (C) Image showing injection site in CeA and cellular expression of hM4Di (red) or EYFP
control (green) virus. (D1) Inhibition of CeA projecting neurons does not significantly alter freezing behavior during training
but reduced cued (D2) and contextual (D3) freezing responses independent of 5-HT terminal stimulation. Data presented as
mean + SEM. *p<0.05, **p<0.005

/hM4Di n = 7; ChR2+/EYFP n = 7; ChR2+/hM4Di n = 6). During acquisition optogenetic
stimulation of 5-HT terminals and CNO infusion into the adBNST did not significantly affect
freezing behavior during conditioning (F(3,21) = 2.254, p = 0.1118; Figure 13D1), but as expected
there was a significant effect of tone presentation over time (F(4,84) = 64.64, p < 0.0001). Tukey’s
post hoc test revealed that there was elevated freezing in control ChR2-/EYFP animals during
CS3 compared to inhibitory DREADD groups, ChR2-/hM4Di (p = 0.0402) and ChR2+/hM4Di
(p = 0.0218) but there was no significant CS x group interaction (F(12, 84) = 1.554, p = 0.1214).
During cued recall, freezing during 10 CS presentations is presented in two-CS bins. During the
recall test, inhibitory DREADD groups exhibited significantly decreased freezing responses to
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tone (Figure 12D2); during cued recall we identified a significant group (F(3,21) = 5.977, p =
0.0090), tone (F(4,84) = 52.58, p < 0.0001), and group x tone interaction (F(12, 84) = 4.553, p <
0.0001). During the first CS-bin females expressing the inhibitory DREADD had significantly
decreased freezing responses compared to females expressing the control virus: ChR2+ hM4Di
vs. ChR2+ EYFP (p < 0.0001), ChR2+ hM4Di vs. ChR2+ EYFP (p = 0.0208), ChR2- hM4Di vs.
ChR2+ EYFP (p<0.0001), and ChR2- hM4Di vs. ChR2- EYFP (p = 0.0183). During the second
CS-bin females expressing the inhibitory DREADD maintained significantly decreased freezing
compared to controls: ChR2+hM4Di vs. ChR2+ EYFP (p = 0.0269), and ChR2- hM4Di vs.
ChR2+ EYFP (p = 0.0279). The following day animals were returned to the conditioning context
for 5 min to measure contextual fear recall. Inhibiting projections to the CeA during conditioning
significantly reduced freezing to the context two days later (F(1,21) = 13.97, p = 0.0012; Figure
13D3). There was no significant effect of 5-HT terminal stimulation in the adBNST (F(1,21) =
0.3861, p = 0.5411) and no significant interaction (F(1,21) = 1.021, p = 0.3238). These data
indicate that in females, projections from the adBNST to the CeA are necessary for cued and
contextual fear responses regardless of elevated 5-HT in this region.
DISCUSSION
To determine if adBNST-to-CeA communication was necessary for the elevated fear
response during times of heightened 5-HT availability, we chemogenetically inhibited this
projection during conditioning. In females that received elevated 5-HT release in the adBNST
(ChR2+) and control animals that did not (ChR2-), inhibition of adBNST-to-CeA
communication significantly decreased cued and contextual fear recall. Unexpectedly, this
experiment suggests that communication from the BNST-to-CeA is modulating fear memory
regardless of whether 5-HT levels have been further enhanced. To our knowledge this is the first
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experiment to illustrate that adBNST projections to the CeA contribute to cued and contextual
fear conditioning in female mice.
Bidirectional inhibitory communication between the BNST and CeA has been welldocumented. Neurons arising from the adBNST send GABAergic projections to the CeL
(Gungor, Yamamoto, & Paré, 2015a; Yamauchi et al., 2018). In turn, the CeL sends a dense
GABAergic projection to the adBNST (Ahrens et al., 2018; Dong & Swanson, 2004a; Goode &
Maren, 2017). Work exploring how the BNST contributes to fear learning found that lesioning
the BNST following cued conditioning did not affect CS-induced recall behavior. However,
lesioning the BNST following contextual fear conditioning reduced freezing during recall
demonstrating a role for the BNST in contextual fear learning (Sullivan et al., 2004). Reversible
inactivation of the BNST with NBQX, an AMPA receptor antagonist, also significantly reduced
contextual fear recall but failed to affect cued learning (Zimmerman & Maren, 2011). Exploring
sex differences in contextual fear learning, Urien et al., (2021) find that lesioning the BNST
reduced contextual fear expression in both sexes. However in non-lesioned animals, only males
exhibited an upregulation of IEG activity within CeA-projecting neurons. Together these
findings suggest that the BNST is involved in contextual fear learning in males, which may be
mediated by communication with the CeA. Interestingly, we find that inhibiting projections from
the adBNST to the CeA in females also reduces contextual fear recall. Although this aligns with
previous work in male rodents, this has not been found in female rats (Urien et al., 2021),
suggesting a possible species difference in extended amygdala communication.
Evidence for BNST activity during cued fear learning paradigms supports a role for this
region beyond contextual fear learning. In vivo unit recordings following training in a
discrimination task identified neurons in the alBNST that are responsive to CS+ presentations
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(Haufler et al., 2013). There is also substantial evidence that elevating extracellular 5-HT in the
BNST enhances cued fear learning (Marcinkiewcz, Mazzone, D’Agostino, Halladay, Hardaway,
Diberto, et al., 2016a; Pelrine et al., 2016b; Ravinder et al., 2013a). Bruzsik et al., 2021 find that
chemogenetically stimulating SOM+ or VGAT+ neurons in the BNST during fear consolidation,
enhances cued fear responses. Interestingly though, chemogenetically inhibiting these neurons
does not significantly reduce cued or contextual fear responses in male mice. Furthermore, the
authors do not identify the CeA as a downstream target of SOM+ or VGAT+ activation in the
BNST. As our current experiment only included female mice, follow-up work will be conducted
in male ChR2- mice to determine if there is a significant contribution of BNST-to-CeA
communication during cued or contextual recall in this sex.
We utilized a retrograde, non-cell type specific inhibitory DREADD to chemogenetically
inhibit all neurons projecting from the adBNST to the CeA and are therefore unable to clearly
state what neuronal cell-type is contributing to our findings. Bruzsik et al. (2021) identify
enhanced fear following activation of SOM+ or VGAT+ but not CRF+ neurons and no effect of
inhibiting these neurons. In male rats, activation of neurons in the adBNST following contextual
fear learning were identified as primarily CRF+ neurons (Urien et al., 2021). During cued fear
learning, optogenetically elevating 5-HT in the adBNST increases activation of CRF+ neurons
via 5-HT2C receptors. However, these are primarily non-projecting local interneurons
(Marcinkiewcz, Mazzone, D’Agostino, Halladay, Hardaway, Diberto, et al., 2016a), so it is
unclear if CRF+ projections to the CeA contribute to the increase in cued fear expression seen in
our experiments.
Neurons within the adBNST have been characterized based on patch-clamp
electrophysiology. In vitro recordings of adBNST neurons projecting to the CeA have been
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classified as primarily Type II neurons – neurons that typically exhibit rebound spiking
following hyperpolarizing current, and exhibit burst firing with depolarizing current. These
neurons are electrophysiologically distinct from cells projecting to other regions such as the
VTA or lateral hypothalamus (Yamauchi et al., 2018). Type II neurons within the adBNST are
also readily depolarized by CRF (Ide et al., 2013) and express an array of 5-HT-receptors with a
notable lack of 5-HT2C expression (Hazra, Guo, Dabrowska, & Rainnie, 2012b). As this work
was primarily conducted in male rodents, it is unclear if the same cell types exist in our female
mice.
Although the DREADD system is commonly used to manipulate neural circuits (Roth,
2016) the technique is not without controversy. We utilized the ligand CNO to activate inhibitory
hM4D(Gi) DREADDs in our experiment. Although commonly used, research has shown that i.p.
administration of CNO in mice and rats results in metabolic conversion of ~8% of CNO to
clozapine. In mice, clozapine is further metabolized to the pharmacologically active Ndesmethyclozapine (Manvich et al., 2018). Some in vitro work suggests minimal CNO binding at
DREADD sites but instead, high levels of clozapine binding (Gomez et al., 2017) with additional
studies highlighting CNO binding at multiple endogenous receptor sites. In vivo experiments
from Gomez et al., (2017) also indicate that CNO does not readily cross the BBB of rodents,
leading that group to conclude that any behavioral effect is due to clozapine-DREADD
interactions. Other studies have shown that CNO does cross the BBB in mice (Jendryka et al.,
2019), but confirms that CNO may competitively bind to endogenous receptors, including 5-HT1
and 5-HT2 receptor types at concentrations as low as 10µM. Additionally, clozapine alone is
pharmacologically active at dopamine and 5-HT1 and 5-HT2 receptor types (Szlachta et al.,
2018).
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Our approach of utilizing a local microinfusion of CNO directly into the adBNST avoids
complications resulting from liver-dependent CNO→clozapine metabolism and potential issues
concerning BBB penetration. We utilized the commonly employed CNO concentration of 1mM
CNO in our experiment and did not detect an effect of CNO alone in our behavioral paradigm.
Mahler and Aston-Jones (2018) argue that despite in vitro observations that 10uM CNO can
interact with endogenous receptors, many studies utilize a 1mM CNO infusion in a variety of
brain regions and do not identify off-target effects of CNO (Lichtenberg et al., 2017; Mahler et
al., 2014; McGlinchey & Aston-Jones, 2018). The authors also note that infusion of CNO into
targeted brain regions in vivo may result in significant diffusion upon injection, so even
relatively high concentration 1mM CNO infusions will be quickly diluted.
We believe we have identified a novel role of adBNST-to-CeA communication during
fear learning in female mice. Our data indicate that this projection contributes to auditory and
contextual fear learning regardless of whether or not 5-HT levels were manipulated in the
adBNST. We are planning to next inhibit CeA-projecting neurons in the adBNST of males to
determine how this projection influences fear expression. Follow-up experiments are also needed
to determine cell-type specificity of the BNST-to-CeA projections in females.
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CHAPTER FIVE
General Discussion & Future Directions
PTSD is characterized by intense fearful memory formation associated with trauma
exposure. Women are at increased risk for developing PTSD (Justice & Brandt, 2010; Tolin &
Foa, 2006). In clinical populations, there is evidence that 5-HT dysregulation may contribute to
development of PTSD (Murrough et al., 2011; Southwick et al., 1997) and medications that
interact with the 5-HT system, such as SSRIs, are often used to treat symptoms (Seedat, Lockhat,
Kaminer, Zungu-Dirwayi, & Stein, 2001; Soraya Seedat et al., 2004; Tucker et al., 2001), albeit
with mixed efficacy (Hertzberg et al., 2000), and a significant therapeutic lag (Quitkin et al.,
1997; Taylor et al., 2006). A model of fear learning used to investigate the neurobiological
underpinnings of emotional learning associated with PTSD is Pavlovian fear conditioning (Milad
& Quirk, 2012; Parsons & Ressler, 2013).
Using a preclinical rodent model of auditory conditioning, the amygdala has been
identified as a necessary brain region for cued fear acquisition and expression (Phillips &
LeDoux, 1992; Rogan et al., 1997). Although once thought to serve only as an output pathway
for generating conditioned responses, the CeA also contributes to fear acquisition (Ciocchi et al.,
2010; Keifer et al., 2015; Wilensky et al., 2006). Together the CeA and the BNST are both part
of the extended amygdala. The BNST is a heterogeneous and sexually dimorphic structure
originally thought only to contribute to anxiety or innate fear expression (Davis et al., 1997;
Walker & Davis, 1997). However, further research supports a role for the BNST in cued and
contextual fear expression (Bruzsik et al., 2021; Marcinkiewcz et al., n.d.; Ravinder et al., 2013b;
Sullivan et al., 2004; Zimmerman & Maren, 2011).
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Acute systemic SSRI administration enhances cued fear acquisition and expression
(Burghardt et al., 2007, 2004) and upregulates neuronal activity in the adBNST and CeA (Pelrine
et al., 2016b; Ravinder et al., 2013a). An SSRI induced increase in 5-HT in the adBNST via local
infusion was sufficient to enhance cued fear memory and elevate neuronal activity in both the
adBNST and CeA (Ravinder et al., 2013a), suggesting a role for the BNST in cued fear learning
during times of elevated 5-HT availability.
The goal of this thesis was to better understand the role of the adBNST in fear circuits
during times of elevated 5-HT availability. As the adBNST is a sexually dimorphic region (Hines
et al., 1992; Toufexis et al., 2007; Trainor et al., 2006), we utilized male and female mice to
explore sex differences in behavior and/or neuronal activity. Using vaginal cytology to infer
hormone status, we determined that in our auditory fear conditioning paradigm there was no
relationship between stage of estrous cycle and level of fear learning. Although previous work in
freely cycling rodents suggests hormone status can influence extinction recall (Milad, Igoe,
Lebron-Milad, & Novales, 2009; Velasco, Florido, Milad, & Andero, 2019), but we did not test
extinction recall in our paradigm. Females also exhibited robust freezing behavior during
training, cued recall, and context recall and did not exhibit elevated locomotor activity or
‘darting’ behavior (Gruene et al., 2015). Based on these findings, we did not find it necessary to
continually track hormone status or general locomotor activity during testing.
Following acute systemic citalopram administration (10mg/kg or 20mg/kg), only females
exhibited a dose-dependent increase in cued fear expression. Females also exhibited a significant
increase in c-Fos activity in the alBNST and ovBNST, and CeA when a low dose of citalopram
(10mg/kg) was administered prior to fear conditioning. Notably, citalopram did not upregulate cFos activity in the BLA. Our findings in females are consistent with previous work completed in
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male rats (Burghardt et al., 2007, 2004; Pelrine et al., 2016b; Ravinder et al., 2013a), although
interestingly we do not see a robust citalopram effect on cued recall in male mice. This suggests
that C57/BL6 female mice are more sensitive to SSRI-induced elevations in 5-HT than males.
There is evidence in the literature that SSRI treatment can be modulated by hormone status in
rodents, but this is typically seen following chronic rather than acute treatment (Lebrón-Milad et
al., 2013). There is also evidence that stress exposure differentially affects the timing of c-Fos
expression in male and female rodents (Bland et al., 2005). Although this may have contributed
to the sex difference we find when c-Fos was assayed on the day of fear conditioning, most of
our work demonstrates that there is a robust sex difference twenty-four hours after conditioning,
thereby supporting our conclusion that females are more sensitive to acute elevation in 5-HT
than males.
We then utilized optogenetics to elevate 5-HT with regional and temporal specificity.
Using a mouse line expressing the excitatory channelrhodopsin-2 (ChR2) exclusively in 5-HT
neurons, we stimulated 5-HT terminals in the adBNST concurrent with CS presentation during
conditioning. We again found a sexually dimorphic response to elevating 5-HT availability –
females exhibited more fear during recall while males did not. We did not find an effect of 5-HT
manipulation on contextual fear learning in either sex. This is notable the adBNST has been
shown to be involved in contextual fear expression (Sullivan et al., 2004; Urien et al., 2021).
Furthermore, previous studies that have optogenetically activated 5-HT release during fear
conditioning found an elevation in both cued and contextual fear expression (Marcinkiewcz,
Mazzone, D’Agostino, Halladay, Hardaway, Diberto, et al., 2016a).
WE again found an upregulation of c-Fos activity in females but not males following
conditioning with optogenetic stimulation. In this experiment, 5-HT induced upregulation of c-
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Fos expression was restricted to the ovBNST and CeA in females. A subset of males and females
had local field potentials recorded in the adBNST and CeA during fear learning and recall. We
identified a role for 5-HT in elevating coherence between the adBNST and CeA in high gamma
(90 – 120 Hz) during early recall in females. Previous studies focused on oscillations in cued
cued fear paradigms highlight an important role for theta power in the BLA, and theta coherence
across the BLA and mPFC, in mediating communication during threat. Future analyses will
determine if 5-HT manipulation alters theta-gamma coupling in the adBNST and/or CeA of
females. These findings strongly indicate that BNST-to-CeA communication mediates increases
in fear expression during times of heightened 5-HT availability in females.
To evaluate whether there are sex differences in 5-HT projections to the adBNST that
could be contributing to our behavioral findings, we injected the retrograde tracer CTB into the
adBNST to fluorescently tag raphe neurons. Interpretation of our findings is limited due to low
sample size caused by off-target injections. Statistically we did not identify a difference in the
number of 5-HT neurons projecting to the adBNST. We are increasing our sample size to further
address this issue. Notably we did not identify 5-HT projections to the adBNST that co-express
vGlut3 (Liu et al., 2014), suggesting that our optogenetic manipulation does not affect glutamate
release. For a more robust understanding of 5-HT release in this region, in vivo microdialysis
could be used to quantify extracellular levels of 5-HT and determine if there are sex differences
in release.
Based on our SSRI and optogenetic experiments, we hypothesized that in 5-HT promotes
adBNST-to-CeA communication in females and this this mediates enhanced the enhancement in
fear expression that we find. Bidirectional communication within the adBNST and CeA is well
documented – they send inhibitory GABAergic projections to each other (Dong & Swanson,
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2004a; Gungor, Yamamoto, & Paré, 2015a) but sex differences in these pathways have not been
thoroughly explored. We chemogenetically inhibited projections from the adBNST to the CeA in
females and optogenetically stimulated 5-HT terminals in the adBNST during auditory fear
conditioning. Inhibiting this pathway significantly reduced cued and contextual fear regardless of
5-HT manipulation. These findings indicate that adBNST-to-CeA communication in female mice
is not dependent on elevated 5-HT availability. However, this does not rule out the possibility
that communication between these regions is affected when extracellular levels of 5-HT are high.
Although this finding was unexpected, to date there has not been a thorough investigation of
BNST-to-CeA communication in female rodents during auditory fear learning. In clinical
research, women exhibit elevated BNST connectivity to other brain regions involved in anxiety
and fear behaviors including the amygdala, nucleus accumbens and hippocampus compared to
men at baseline (Avery et al., 2014; Flook et al., 2020). Furthermore, women diagnosed with
PTSD exhibit sustained BNST activation following exposure to aversive stimuli (Brinkmann et
al., 2017). Based on these findings we will next inhibit projections from the adBNST to the CeA
in males (ChR2-) to determine if adBNST-to-CeA communication is also necessary for recall of
a cued and/or contextual fear memory in this sex.
Future Directions
In both our optogenetic and acute citalopram experiment, we identified altered pre-CS
freezing in males when placed in the recall context. In both experiments, serotonergic
manipulation decreased pre-CS freezing behavior compared to controls. Although subtraction of
pre-CS freezing from CS-evoked behavior has previously been done (Allsop et al., 2018), we
determined that such an analysis of our data would be misleading. Bruzsik et al., (2021) recently
noted altered baseline freezing behavior in male mice in a recall, or ‘safe’, context, but found
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elevated pre-CS freezing in their experimental group, rather than their control group. The authors
describe this as an alteration in contextual discrimination. It is possible that our serotonergic
manipulation promotes contextual discrimination, as reflected by a reduction in pre-CS freezing.
Alternatively, it we may be reducing an anxiety
phenotype. Follow-up studies employing an
innate anxiety test, (i.e. open field or elevated
plus maze) before and after fear learning will
help to clarify these unexpected behavioral
findings.
Our experiments do not identify a
mechanism by which elevated 5-HT alters
Figure 14. Males exhibit greater 5-HT3, and 5-HT7
transcript levels in the adBNST compared to
females. Transcript levels normalized to GAPDH for
(A) 5Htr1a (B) 5Htr2a, (C) 5Htr2c, (D) 5Htr3a, (E)
5Htr7, or (F) Crh, corticotropin-releasing hormone.
Data presented as mean + SEM. *p<0.05 **p<0.005

cellular activity in the adBNST. Previous
research has focused on the 5-HT2C receptor in
mediating 5-HT-induced enhancement in fear

learning. For example, citalopram-induced increases in fear recall can be blocked by pretreatment with a 5-HT2C, but not a 5-HT3 receptor antagonist (Burghardt et al., 2007). Infusion of
a 5-HT2C antagonist into the adBNST also blocks SSRI induced elevations in fear recall (Pelrine
et al., 2016b). In vitro recordings following optogenetic stimulation of 5-HT terminals in the
BNST, demonstrate that post synaptic depolarization can be blocked by a 5-HT2C antagonist
(Marcinkiewcz, Mazzone, D’Agostino, Halladay, Hardaway, Diberto, et al., 2016a). Together
these findings strongly implicate the 5-HT2C receptor in mediating SSRI-induced increases in
fear learning through neural activation in the adBNST.
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Sex differences in 5-HT receptor
expression in the adBNST could account for the
behavioral effects that we report. We are therefore
currently analyzing 5-HT receptor expression
levels in our male and female mice. Using ChR2animals, we extracted adBNST samples following
Figure 15. Proposed circuit underlying enhanced
fear learning in female mice. During times of
elevated 5-HT availability within the adBNST, 5-HT
may activate the 5-HT2C receptor on local
GABAergic interneurons. Activation of this local
interneuron would inhibit GABAergic projections
from the adBNST to the CeA. This would ultimately
disinhibit neurons in the CeA and result in an elevated
fear response.

decapitation. Preliminary qPCR analysis (Figure
14) found greater transcript levels of 5-HT7 (p =
0.0461), 5-HT3 (p = 0.0013) and a near significant
increase in 5-HT1A (p = 0.0508) in males

compared to females. Interestingly, we did not identify a sex difference in 5-HT2C receptor
expression. Previous work suggests that CeA-projecting neurons lack 5-HT2C expression (Hazra
et al., 2012b; Yamauchi et al., 2018) and that this receptor sub-type is instead located on local
interneurons which influence projection activity (Marcinkiewcz, Mazzone, D’Agostino,
Halladay, Hardaway, Diberto, et al., 2016a). Our 5-HT receptor expression data is still
preliminary and the literature strongly supports a role for 5HT2C receptor activation of local
inhibitory interneurons during times of elevated 5-HT availability in the adBNST. Conceptually,
this elevated interneuron activation would then inhibit GABAergic projection neurons to the
CeA, ultimately disinhibiting CeA neural activity and enhancing fear learning (Figure 15).
Future work will confirm our preliminary transcript findings in the adBNST. Infusion of specific
5-HT receptor antagonists into the adBNST prior to fear conditioning with optogenetic
manipulation would provide further insight into which 5-HT receptor(s) are contributing to our
behavioral findings.
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Conclusion
Taken together, our findings illustrate a sexually dimorphic response to elevated 5-HT
during fear conditioning. In females, this response is presumably mediated by adBNST-to-CeA
communication. Inhibition of projections from the adBNST to the CeA drastically reduces cued
and contextual fear learning, indicating that this pathway contributes significantly to fear
learning. Ongoing analyses of electrophysiology data will provide insight into how an increase in
5-HT in the adBNST affects communication between these brain regions. This work emphasizes
the importance of using both sexes in preclinical fear learning paradigms.
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